Structure of Enzalutamide
CAS No.: 915087-33-1
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Enzalutamide (MDV3100) is an androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cells. It also activates autophagy.
Synonyms: MDV3100
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Hwang, Dong-Jin ; He, Yali ; Ponnusamy, Suriyan ; Thiyagarajan, Thirumagal ; Mohler, Michael L. ; Narayanan, Ramesh , et al.
Abstract: A major challenge for new drug discovery in the area of androgen receptor (AR) antagonists lies in predicting the druggable properties that will enable small mols. to retain their potency and stability during further studies in vitro and in vivo. Indole (compound 8) is a first-in-class AR antagonist with very high potency (IC50 = 0.085 μM) but is metabolically unstable. During the metabolic studies described herein, we synthesized new small mols. that exhibit significantly improved stability while retaining potent antagonistic activity for an AR. This structure-activity relationship (SAR) study of more than 50 compounds classified with three classes (Class I, II, and III) and discovered two compounds (32c and 35i) that are potent AR antagonists (e.g., IC50 = 0.021 μM, T1/2 = 120 min for compound 35i). The new antagonists exhibited improved in vivo pharmacokinetics (PK) with high efficacy antiandrogen activity in Hershberger and antiandrogen Enz-Res tumor xenograft models that overexpress AR (LNCaP-AR).
Show More >
CAS No. : | 915087-33-1 |
Formula : | C21H16F4N4O2S |
M.W : | 464.44 |
SMILES Code : | CC1(C(N(C(N1C2=CC(F)=C(C(NC)=O)C=C2)=S)C3=CC(C(F)(F)F)=C(C#N)C=C3)=O)C |
Synonyms : |
MDV3100
|
MDL No. : | MFCD14155804 |
InChI Key : | WXCXUHSOUPDCQV-UHFFFAOYSA-N |
Pubchem ID : | 15951529 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302 |
Precautionary Statements: | P280-P305+P351+P338 |
Target |
|
In Vitro:
Concentration | Treated Time | Description | References |
Myc-CaP cells | 50 µM | >12 months | To generate Enzalutamide-resistant cell lines, it was found that immune-related signaling pathways were suppressed in resistant cells | PMC10163595 |
C4-2B cells | 20 µM | To study the mechanisms of Enzalutamide resistance, it was found that immune-related signaling pathways were suppressed in resistant cells | PMC10163595 | |
PC-3 | 10 μΜ | 5 days | Enzalutamide treatment did not induce senescence in PC-3 cells but increased CDC6 levels. | PMC10386253 |
C4-2B | 10 μΜ | 5 days | Enzalutamide treatment did not induce senescence in C4-2B cells but increased CDC6 levels. | PMC10386253 |
LNCaP | 10 μΜ | 5 days | Enzalutamide treatment induced senescence in LNCaP cells via reduction of the replication licensing factor CDC6. | PMC10386253 |
CWR22Rv1 cells | 20 μM | 3 and 5 days | To evaluate the combined inhibitory effect of Enzalutamide and Niclosamide on CWR22Rv1 cells, the results showed significant growth inhibition with the combination treatment. | PMC4058390 |
C4-2B MR cells | 20 μM | 48 h | To evaluate the inhibitory effect of Enzalutamide on C4-2B MR cells, the results showed limited growth inhibition of C4-2B MR cells by Enzalutamide. | PMC4058390 |
VCaP cells | 5 µM | 48 h | To investigate the effect of ROR-γ antagonists on AR-V7 gene expression, results showed that XY018 and SR2211 significantly inhibited AR-V7 gene expression. | PMC5030109 |
C4-2B cells | 5 µM | 48 h | To investigate the effect of ROR-γ antagonists on AR gene expression, results showed that SR2211 significantly inhibited AR gene expression. | PMC5030109 |
In Vivo:
Administration | Dosage | Frequency | Description | References |
FVB mice | Myc-CaP tumor model | Oral | 25 mg/kg | 5 days per week for 2 weeks | To study the effects of Enzalutamide on immune cells in the tumor microenvironment, it was found that Enzalutamide treatment decreased CD8+ T-cell numbers and increased M-MDSC and PD-L1 expression | PMC10163595 |
SCID mice | LNCaP and C4-2B xenograft models | Oral gavage | 10 mg/kg | 8 consecutive days | Enzalutamide treatment induced senescence in LNCaP xenografts, reduced CDC6 levels, increased p21WAF1/Cip1 expression, and attenuated EMT. In C4-2B xenografts, Enzalutamide treatment did not induce senescence but increased CDC6 levels and EMT activity. | PMC10386253 |
SCID mice | CWR22Rv1 tumor model | Oral | 25 mg/kg | 3 weeks | To evaluate the combined inhibitory effect of Enzalutamide and Niclosamide on CWR22Rv1 tumors, the results showed significant tumor growth inhibition with the combination treatment. | PMC4058390 |
Mice | C4-2B xenograft model | Intraperitoneal injection | 5 mg/kg | 5 times a week for 24 days | To investigate the effect of SR2211 on tumor growth in the C4-2B xenograft model, results showed that SR2211 significantly inhibited tumor growth. | PMC5030109 |
Mice | Ptenpc-/- mice | Oral | 30 mg/kg | Daily for 12 weeks | Anti-IL23 treatment can reverse castration resistance in prostate cancer and enhance the efficacy of ENZA. | PMC6461206 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT01650194 | Metastatic Castration-Resistan... More >>t Prostate Cancer Less << | Phase 2 | Completed | - | United States, Texas ... More >> Site US2492 MD Anderson Cancer Ctr Houston, Texas, United States, 77030 Less << |
NCT03478904 | Prostate Cancer | Phase 1 | Recruiting | April 30, 2019 | United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 Less << |
NCT03305224 | Castration-resistant Prostate ... More >>Cancer Bone Metastases Less << | Phase 2 | Recruiting | December 2019 | Japan ... More >> Osaka City University Graduate School of Medicine Recruiting Osaka, Japan, 545-8585 Contact: Taro Iguchi, MD, PhD Less << |
NCT02286921 | Castration Resistant Metastati... More >>c Prostate Cancer Less << | Phase 2 | Active, not recruiting | December 2019 | United States, District of Col... More >>umbia Sibley Memorial Hospital Washington, District of Columbia, United States, 20016 United States, Maryland SKCCC at Johns Hopkins Baltimore, Maryland, United States, 21205 Less << |
NCT02300610 | Bladder Cancer ... More >> Carcinoma, Transitional Cell Renal Pelvis Cancer Ureter Cancer Urethra Cancer Less << | Phase 1 | Active, not recruiting | August 2019 | United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Minnesota University of Minnesota, Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 Less << |
NCT03531827 | Metastatic Castration Resistan... More >>t Prostate Cancer Prostate Neoplasms Less << | Phase 2 | Recruiting | June 30, 2020 | United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 Less << |
NCT01911715 | Healthy Subjects|Pharmacokinet... More >>ics of MDV3100 Less << | PHASE1 | COMPLETED | 2025-07-11 | PRA International, Zuidlaren, ... More >>9471GP, Netherlands Less << |
NCT01565928 | Prostate Cancer | PHASE1 | COMPLETED | 2018-02-26 | Memorial Sloan Kettering Cance... More >>r Center, New York, New York, 10065, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, United States|Virginia Oncology Associates, Norfolk, Virginia, 23502, United States Less << |
NCT03246347 | Prostate Cancer ... More >> Prostate Adenocarcinoma Less << | Phase 2 | Recruiting | August 2020 | United States, North Carolina ... More >> Levine Cancer Institute Recruiting Charlotte, North Carolina, United States, 28204 Contact: Sandra Samu-Arce, RN 980-993-5484 sandra.samuarce@atriumhealth.org Less << |
NCT02254785 | Metastatic Castration-Resistan... More >>t Prostatic Cancer Less << | Phase 2 | Active, not recruiting | May 2020 | Australia, Victoria ... More >> Box Hill Hospital Box Hill, Victoria, Australia, 3128 Monash Health-Monash Medical Centre Clayton, Victoria, Australia, 3168 Peter MacCallum Cancer Centre Melbourne, Victoria, Australia, 3000 Canada, Alberta Tom Baker Cancer Cantre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Kelowna Kelowna, British Columbia, Canada, V1Y 5J3 BCCA- Vancouver Center Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Nova Scotia QEII Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Durham Regional Cancer Centre (Lakeridge Health) Oshawa, Ontario, Canada, L1G 2B9 The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Jewish General Hospital Montreal, Quebec, Canada, H3T 1E2 Canada, Saskatchewan Saskatoon Cancer Center Saskatoon, Saskatchewan, Canada, 27N 4H4 Less << |
NCT03314324 | Metastatic Castrate-resistant ... More >>Prostate (CRPC) Cancer Less << | Phase 2 | Recruiting | January 2022 | France ... More >> Gustave Roussy Recruiting Villejuif, Val De Marne, France, 94805 Contact: Karim FIZAZI, MD 0142114317 ext +33 karim.fizazi@gustaveroussy.fr Contact: Geraldine MARTINEAU, MD 0142115607 ext +33 geraldine.martineau@gustaveroussy.fr Principal Investigator: Karim FIZAZI, MD Less << |
NCT03344211 | Castration-Resistant Prostate ... More >>Carcinoma Prostate Carcinoma Metastatic in the Bone Stage IV Prostate Cancer Less << | Phase 2 | Recruiting | November 21, 2023 | United States, California ... More >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Cheryl Kefauver, RN 323-865-0459 Cheryl.Kefauver@med.usc.edu Principal Investigator: David I Quinn, MD Cedars Sinai Medical Center Not yet recruiting Los Angeles, California, United States, 90048 Contact: Edwin M. Posadas 310-423-7600 Edwin.posadas@csmc.edu Principal Investigator: Edwin M. Posadas Less << |
NCT02215096 | Cancer | Phase 1 | Recruiting | December 2, 2019 | United States, California ... More >> GSK Investigational Site Completed Duarte, California, United States, 91010 GSK Investigational Site Completed Los Angeles, California, United States, 90089 GSK Investigational Site Recruiting Los Angeles, California, United States, 90095 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, District of Columbia GSK Investigational Site Recruiting Washington, District of Columbia, United States, 20007 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Michigan GSK Investigational Site Recruiting Detroit, Michigan, United States, 48201 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, New York GSK Investigational Site Completed New York, New York, United States, 10016 United States, Texas GSK Investigational Site Recruiting Houston, Texas, United States, 77030 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Utah GSK Investigational Site Terminated Salt Lake City, Utah, United States, 84112-5550 United Kingdom GSK Investigational Site Recruiting London, United Kingdom, SE1 9RT Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Sutton, United Kingdom, SM2 5PT Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Less << |
NCT02588001 | Prostate Cancer | COMPLETED | 2021-03-31 | Kagawa University Faculty of M... More >>edicine, Kita-gun, Kagawa-prefecture, 761-0793, Japan|University of Miyazaki Faculty of Medicine, Miyazaki-city, Miyazaki-prefecture, 889-1692, Japan|Tokyo Medical Center, Meguro-ku, Tokyo, 152-8902, Japan|The Jikei university school of medicin, Minato-ku, Tokyo, 105-8461, Japan Less << | |
NCT03395197 | mCRPC | Phase 3 | Recruiting | November 2024 | United States, Alaska ... More >> Alaska Urological Institute dba Alaska Clinical Research Center Not yet recruiting Anchorage, Alaska, United States, 99503 United States, Arizona Urological Associates of Southern Arizona, PC Recruiting Tucson, Arizona, United States, 85715 Urological Associates of Southern Arizona, P.C. Recruiting Tucson, Arizona, United States, 85741 United States, California Marin Cancer Care, Inc. Not yet recruiting Greenbrae, California, United States, 94904 San Diego Clinical Trials Not yet recruiting San Diego, California, United States, 92120 United States, Colorado The Urology Center of Colorado Recruiting Denver, Colorado, United States, 80211 United States, Nebraska GU Research Network/Urology Cancer Center Recruiting Omaha, Nebraska, United States, 68130 United States, New Jersey New Jersey Urology, LLC Not yet recruiting Voorhees, New Jersey, United States, 08043 United States, New York Premier Medical Group of the Hudson Valley PC Not yet recruiting Poughkeepsie, New York, United States, 12601 Associated Medical Professionals of New York, PLLC Not yet recruiting Syracuse, New York, United States, 13210 United States, Ohio TriState urologic Services PSC Inc., dba The Urology Group Not yet recruiting Cincinnati, Ohio, United States, 45212 United States, South Carolina Carolina Urologic Research Center Recruiting Myrtle Beach, South Carolina, United States, 29572 United States, Tennessee Urology Associates P.C. Not yet recruiting Nashville, Tennessee, United States, 37209 United States, Utah University of Utah, Huntsman Cancer Hospital Recruiting Salt Lake City, Utah, United States, 84112 University of Utah, Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Less << |
NCT01911728 | Pharmacokinetics of MDV3100 ... More >> Castration Resistant Prostate Cancer (CRPC) Less << | Phase 1 | Completed | - | South Africa ... More >> Parexel George, South Africa Parexel/Qdot Pharma Port Elizabeth, South Africa Less << |
NCT01901133 | Pharmacokinetics of MDV3100|He... More >>althy Subjects|Kidney Diseases Less << | PHASE1 | COMPLETED | 2025-01-12 | Arensia, Chisinau, Moldova, Re... More >>public of Less << |
NCT01995513 | Prostate Cancer | Phase 4 | Active, not recruiting | May 31, 2024 | - |
NCT02012296 | Hormone-resistant Prostate Can... More >>cer Recurrent Prostate Cancer Stage IV Prostate Cancer Less << | Phase 1 Phase 2 | Recruiting | December 1, 2021 | United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Recruiting Chicago, Illinois, United States, 60637-1470 Contact: Kelly O'Connor 773-702-4653 koconnor@medicine.bsd.uchicago.edu Principal Investigator: Russell Z. Szmulewitz Cancer Care Specialists of Central Illinois (Decatur) /Decatur Memorial Hospital Recruiting Decatur, Illinois, United States, 62526 Contact: James Wade, MD 217-876-6600 NorthShore University Health System Recruiting Evanston, Illinois, United States, 60201 Contact: Daniel Shevrin, MD 224-364-7100 dshevrin@northshore.org United States, Michigan Wayne State University Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Elisabeth Heath, MD 313-576-8624 heathe@karmanos.org Less << |
NCT02799745 | Prostate Cancer | Phase 2 | Active, not recruiting | August 2020 | - |
NCT01995513 | - | Active, not recruiting | - | - | |
NCT02607228 | Metastatic Castrate-Resistant ... More >>Prostate Cancer Less << | Phase 1 Phase 2 | Active, not recruiting | December 2018 | United States, California ... More >> San Francisco, California, United States, 94158 United States, Maryland Baltimore, Maryland, United States, 21231 United States, Massachusetts Boston, Massachusetts, United States, 02114 United States, North Carolina Durham, North Carolina, United States, 27710 Less << |
NCT02491411 | Hormone-Resistant Prostate Can... More >>cer Metastatic Prostate Carcinoma Prostate Adenocarcinoma Stage IV Prostate Cancer Less << | Not Applicable | Terminated(The study is termin... More >>ated due to lower enrollment) Less << | - | United States, Maryland ... More >> Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 Less << |
NCT01885949 | Prostate Cancer | Phase 2 | Active, not recruiting | June 2019 | United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less << |
NCT02125357 | Metastatic Castration-Resistan... More >>t Prostate Cancer Less << | Phase 2 | Active, not recruiting | July 2019 | Canada, British Columbia ... More >> BC Cancer Agency - Abbotsford Abbotsford, British Columbia, Canada, V2S 0C2 BC Cancer Agency - Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 BC Cancer Agency - Centre for the North Prince George, British Columbia, Canada, V2N 7E9 BC Cancer Agency - Fraser Valley Surrey, British Columbia, Canada, V3V 1Z2 Vancouver Prostate Centre Vancouver, British Columbia, Canada, V5Z 1M9 BC Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 BC Cancer Agency - Vancouver Island Victoria, British Columbia, Canada, V8R 6V5 Less << |
NCT02833883 | Prostate Cancer ... More >> Castration Resistant Prostate Cancer Less << | Phase 1 | Recruiting | July 2019 | United States, California ... More >> University of California San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Felix Feng, MD 415-502-7222 United States, Maryland John Hopkins Medical Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Emmanuel Antonarakis, MBBCh 410-464-6641 Principal Investigator: Emmanuel Antonarakis, MBBCh United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Dana Rathkopf, MD 646-422-4379 Contact: Wassim Abida, MD, PhD 646-422-4633 Principal Investigator: Dana Rathkopf, MD United States, Washington University of Washington School of Medicine Recruiting Seattle, Washington, United States, 98109 Contact: Heather Cheng, MD, PhD 206-606-7486 Principal Investigator: Heather Cheng, MD, PhD Less << |
NCT02749903 | Salivary Cancer | Phase 2 | Active, not recruiting | - | - |
NCT01091103 | Metastatic Progressive Castrat... More >>ion-resistant Prostate Cancer Less << | PHASE2 | COMPLETED | 2013-08-31 | MD Anderson Cancer Center, Hou... More >>ston, Texas, 77303, United States Less << |
NCT02669771 | - | Active, not recruiting | November 2018 | Japan ... More >> Aichi, Japan Akita, Japan Aomori, Japan Chiba, Japan Ehime, Japan Fukui, Japan Fukuoka, Japan Fukushima, Japan Gifu, Japan Gunma, Japan Hiroshima, Japan Hokkaido, Japan Hyogo, Japan Ibaraki, Japan Ishikawa, Japan Iwate, Japan Kagawa, Japan Kagoshima, Japan Kanagawa, Japan Kochi, Japan Kumamoto, Japan Kyoto, Japan Mie, Japan Miyagi, Japan Miyazaki, Japan Nagano, Japan Nagasaki, Japan Nara, Japan Niigata, Japan Oita, Japan Okayama, Japan Okinawa, Japan Osaka, Japan Saga, Japan Saitama, Japan Shiga, Japan Shimane, Japan Shizuoka, Japan Tochigi, Japan Tokushima, Japan Tokyo, Japan Tottori, Japan Toyama, Japan Wakayama, Japan Yamagata, Japan Yamaguchi, Japan Yamanashi, Japan Less << | |
NCT02885649 | Clear Cell Renal Cell Carcinom... More >>a Stage I Renal Cell Cancer Less << | Early Phase 1 | Recruiting | January 2020 | United States, New Jersey ... More >> Rutgers Cancer Institute of New Jersey Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Eric A. Singer 732-235-8675 singerea@cinj.rutgers.edu Principal Investigator: Eric A. Singer Less << |
NCT02491411 | - | Terminated(The study is termin... More >>ated due to lower enrollment) Less << | - | - | |
NCT01091103 | Metastatic Progressive Castrat... More >>ion-resistant Prostate Cancer Less << | PHASE2 | COMPLETED | 2013-08-31 | MD Anderson Cancer Center, Hou... More >>ston, Texas, 77303, United States Less << |
NCT02640534 | Cancer of the Prostate ... More >> Prostate Cancer Less << | Phase 2 | Recruiting | June 2026 | Switzerland ... More >> Kantonsspital Aarau Recruiting Aarau, Switzerland, 5001 Contact: Tobias Wehrhahn, Dr. med. +41 62 838 60 50 tobias.wehrhahn@ksa.ch Principal Investigator: Tobias Wehrhahn, Dr. med. Universitaetsspital Basel Recruiting Basel, Switzerland, 4031 Contact: Sacha Rothschild, MD +41 61 265 25 25 sacha.rothschild@usb.ch Principal Investigator: Sacha Rothschild, MD Istituto Oncologico della Svizzera Italiana (IOSI) Recruiting Bellinzona, Switzerland, 6500 Contact: Ricardo Pereira Mestre, MD +41 91 811 84 46 ricardo.pereiramestre@eoc.ch Principal Investigator: Ricardo Pereira Mestre, MD Kantonsspital Graubuenden Recruiting Chur, Switzerland, 7000 Contact: Richard Cathomas, MD +41 81 256 66 95 richard.cathomas@ksgr.ch Principal Investigator: Richard Cathomas, MD Spital Thurgau AG Recruiting Frauenfeld, Switzerland, CH-8500 Contact: Regina Woelkly, MD +41 52 723 76 91 regina.woelkly@stgag.ch Principal Investigator: Regina Woelkly, MD Hôpitaux Universitaires de Genève Recruiting Genève 14, Switzerland, 1211 Contact: Anna Patrikidou, MD +41 79 553 60 99 anna.patrikidou@hcuge.ch Principal Investigator: Anna Patrikidou, MD CCAC Lausanne Recruiting Lausanne, Switzerland, 1004 Contact: Pierre Bohanes, MD +41 (21) 646 79 94 pbohanes@bluewin.ch Principal Investigator: Pierre Bohanes, MD Luzerner Kantonsspital Recruiting Luzern 16, Switzerland, 6000 Contact: Beat Müller, MD +41 41 205 58 60 beat.mueller@luks.ch Principal Investigator: Beat Müller, MD Hôpital du Valais Recruiting Martigny, Switzerland, 1920 Contact: Sandro Anchisi, MD +41 27 603 90 00 sandro.anchisi@hopitalvs.ch Principal Investigator: Sandro Anchisi, MD Kantonsspital Olten Recruiting Olten, Switzerland, CH-4600 Contact: Walter Mingrone, MD 41-62-311-4241 wmingrone_ol@spital.ktso.ch Principal Investigator: Walter Mingrone, MD Hôpital du Valais Recruiting Sion, Switzerland, 1951 Contact: Sandro Anchisi, MD +41 27 603 45 00 sandro.anchisi@hopitalvs.ch Principal Investigator: Sandro Anchisi, MD Bürgerspital Solothurn Recruiting Solothurn, Switzerland, CH-4500 Contact: Philippe von Burg, MD +41 32 627 47 00 philippe.vonburg@spital.so.ch Principal Investigator: Philippe von Burg, MD Kantonsspital St. Gallen Recruiting St. Gallen, Switzerland, 9007 Contact: Christian Rothermundt, MD +41 71 494 11 63 christian.rothermundt@kssg.ch Principal Investigator: Christian Rothermundt, MD Kantonsspital Winterthur Recruiting Winterthur, Switzerland, 8401 Contact: Natalie Fischer, MD +41 052 266 40 87 natalie.fischer@ksw.ch Principal Investigator: Natalie Fischer, MD Stadtspital Triemli Recruiting Zürich, Switzerland, 8063 Contact: Aleksandra Marek, Dr. med. +41 (44) 466 11 11 aleksandra.marek@triemli.zuerich.ch Principal Investigator: Aleksandra Marek, Dr. med. UniversitätsSpital Zürich Recruiting Zürich, Switzerland, 8091 Contact: Thomas Hermanns, MD +41 44 255 11 11 thomas.hermanns@usz.ch Principal Investigator: Thomas Hermanns, MD Less << |
NCT02935205 | Metastatic Prostate Carcinoma ... More >> Recurrent Prostate Carcinoma Stage IV Prostate Cancer Less << | Phase 1 Phase 2 | Recruiting | December 2020 | United States, California ... More >> University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Chong-Xian Pan 916-734-3771 cxpan@ucdavis.edu Principal Investigator: Chong-Xian Pan Less << |
NCT02555189 | Hormone-Resistant Prostate Can... More >>cer Metastatic Prostate Carcinoma Prostate Carcinoma Metastatic in the Bone Stage IV Prostate Cancer Less << | Phase 1 Phase 2 | Recruiting | May 2021 | United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: David Smith, MD 734-763-6537 United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Gurkamal Chatta, MD Gurkamal.Chatta@RoswellPark.org Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Susan Slovin, MD, PhD 646-422-4470 United States, Pennsylvania Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: William Kevin Kelly, MD 215-955-8874 Contact: Clinical Trials Office 215-955-1661 Principal Investigator: William Kevin Kelly, MD Sub-Investigator: Robert Den, MD Sub-Investigator: Jean Hoffman-Censits, MD Sub-Investigator: Jianqing Lin, MD Sub-Investigator: Leonard Gomella, MD Sub-Investigator: Edouard Trabulsi, MD Sub-Investigator: Costas Lallas, MD Less << |
NCT03704519 | Cerebrovascular Circulation | Phase 1 | Recruiting | July 24, 2019 | United Kingdom ... More >> Academic Neuroscience Centre, Kings College Recruiting London, United Kingdom, SE5 8AF Less << |
NCT02091960 | - | Active, not recruiting | - | - | |
NCT02091960 | HER2 Amplified ... More >> Advanced Breast Cancer Human Epidermal Growth Factor Receptor 2 (HER2) Less << | Phase 2 | Active, not recruiting | December 2019 | - |
NCT01547299 | Prostate Cancer | Phase 2 | Completed | - | United States, Massachusetts ... More >> Boston, Massachusetts, United States, 02215 United States, Washington Seattle, Washington, United States, 98195 Canada, British Columbia Vancouver, British Columbia, Canada, V5Z 1M9 Canada, Ontario Toronto, Ontario, Canada, M5G 2M9 Less << |
NCT01547299 | - | Completed | - | - | |
NCT02339168 | Prostate Cancer | Phase 1 | Active, not recruiting | December 2019 | United States, California ... More >> University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 Less << |
NCT02099864 | Castration-Resistant Prostate ... More >>Carcinoma|Metastatic Malignant Neoplasm in the Bone|Metastatic Malignant Neoplasm in the Soft Tissues|Metastatic Prostate Adenocarcinoma|Recurrent Prostate Carcinoma|Stage III Prostate Adenocarcinoma AJCC v7|Stage IV Prostate Adenocarcinoma AJCC v7 Less << | PHASE2 | COMPLETED | 2024-07-08 | UCSF Medical Center-Mount Zion... More >>, San Francisco, California, 94115, United States|OHSU Knight Cancer Institute, Portland, Oregon, 97239, United States Less << |
NCT01597193 | Breast Cancer | Phase 1 | Completed | - | United States, Colorado ... More >> ATTN-Research Pharmacist Aurora, Colorado, United States, 80045 University of Colorado Cancer Center Aurora, Colorado, United States, 80045 University of Colorado Hospital, Anschutz Outpatient Pavilion Aurora, Colorado, United States, 80045 United States, Connecticut Connecticut Multispecialty Group Enfield, Connecticut, United States, 06082 United States, Florida Florida Cancer Specialists Sarasota, Florida, United States, 34232 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Mississippi The West Clinic, PC Corinth, Mississippi, United States, 38834 The West Clinic Southaven, Mississippi, United States, 38671 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10022 Memorial Sloan Kettering Cancer Center - IDS Pharmacy New York, New York, United States, 10065 Memorial Sloan Kettering Cancer Center - OPD Pharmacy New York, New York, United States, 10065 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Tennessee The West Clinic Germantown, Tennessee, United States, 38138 The West Clinic Memphis, Tennessee, United States, 38104 The West Clinic Memphis, Tennessee, United States, 38120 Tennessee Oncology, PLLC. Nashville, Tennessee, United States, 37203 The Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Less << |
NCT02007512 | - | Active, not recruiting | - | - | |
NCT01663415 | Metastatic Castration-Resistan... More >>t Prostate Cancer Less << | PHASE2 | WITHDRAWN | 2025-10-14 | - |
NCT02057939 | Prostate Cancer | Phase 2 | Active, not recruiting | March 2019 | United States, New Jersey ... More >> Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Wake Forest Baptist Health Winston-Salem, North Carolina, United States, 27157 Less << |
NCT02489123 | Ann Arbor Stage I Mantle Cell ... More >>Lymphoma Ann Arbor Stage II Mantle Cell Lymphoma Ann Arbor Stage III Mantle Cell Lymphoma Ann Arbor Stage IV Mantle Cell Lymphoma Recurrent Mantle Cell Lymphoma Refractory Mantle Cell Lymphoma Less << | Not Applicable | Recruiting | - | United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Ajay K. Gopal 206-606-2037 agopal@uw.edu Principal Investigator: Ajay K. Gopal Less << |
NCT02452008 | Prostate Cancer | Phase 2 | Recruiting | July 2021 | United States, District of Col... More >>umbia Sibley Memorial Hospital Recruiting Washington, District of Columbia, United States, 20016 Contact: Janice Powers, RN 202-660-5772 jpower22@JHMI.EDU Principal Investigator: Channing Paller, MD United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Maha Hussain, MD 312-908-5487 maha.hussain@northwestern.edu Principal Investigator: Maha Hussain, MD University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Russel Szmulewitz, MD 773-702-7609 rszmulew@medicine.bsd.uchicago.edu Contact: Kelly O'Connor 773-702-4653 koconnor@medicine.bsd.uchicago.edu Principal Investigator: Russel Szmulewitz, MD United States, Maryland Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21205 Contact: Channing Paller, MD 410-614-6321 cpaller@JHMI.EDU Contact: Irina Rifkind, RN 410-502-2043 irifkin1@JHMI.EDU Principal Investigator: Channing Paller, MD Less << |
NCT03709550 | Castration Levels of Testoster... More >>one Castration-Resistant Prostate Carcinoma Metastatic Prostate Carcinoma in the Soft Tissue Prostate Carcinoma Metastatic in the Bone PSA Level Greater Than or Equal to Two PSA Progression Stage IV Prostate Cancer AJCC v8 Stage IVA Prostate Cancer AJCC v8 Stage IVB Prostate Cancer AJCC v8 Less << | Phase 1 Phase 2 | Not yet recruiting | August 31, 2020 | United States, New York ... More >> Roswell Park Cancer Institute Not yet recruiting Buffalo, New York, United States, 14263 Contact: Gurkamal S. Chatta 716-845-3117 Gurkamal.Chatta@roswellpark.org Principal Investigator: Gurkamal S. Chatta Less << |
NCT02689427 | Breast Cancer | Phase 2 | Recruiting | September 2021 | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less << |
NCT01302041 | Prostate Cancer | PHASE2 | COMPLETED | 2017-04-27 | Site BE1003, Brussels, 1090, B... More >>elgium|Site BE1001, Brussels, 1200, Belgium|Site BE1002, Kortrijk, 8500, Belgium|Site BE1005, Leuven, 3000, Belgium|Site CZ3006, Olomouc, 77520, Czechia|Site CZ3002, Praha 6, 16000, Czechia|Site DK4001, Aarhus N, 8200, Denmark|Site DK4004, Copenhagen, DK-2100, Denmark|Site DK4002, Herlev, 2730, Denmark|Site DE5005, Aachen, 51074, Germany|Site DE5007, Bonn, 53111, Germany|Site DE5003, Hannover, 30625, Germany Less << |
NCT01889238 | Advanced, Androgen Receptor Po... More >>sitive Triple Negative Breast Cancer Less << | PHASE2 | COMPLETED | 2024-01-10 | Rocky Mountain Cancer Centers,... More >> Colorado Springs, Colorado, 80907, United States|Rocky Mountain Cancer Centers, Lakewood, Colorado, 80228, United States|Rocky Mountain Cancer Center Sky Ridge, Lone Tree, Colorado, 80124, United States|Rocky Mountain Cancer Centers, Lone Tree, Colorado, 80124, United States|Florida Cancer Specialists, Altamonte Springs, Florida, 32701, United States|Florida Cancer Specialists, Bonita Springs, Florida, 34135, United States|Florida Cancer Specialists, Bradenton, Florida, 34209, United States|Florida Cancer Specialists, Brandon, Florida, 33511, United States|Florida Cancer Specialists, Cape Coral, Florida, 33914, United States|Florida Cancer Specialists, Clearwater, Florida, 33761, United States|Florida Cancer Specialists, Fort Myers, Florida, 33905, United States|Florida Cancer Specialist South Division, Fort Myers, Florida, 33908, United States|Florida Cancer Specialists, Fort Myers, Florida, 33908, United States|Florida Cancer Specialists, Fort Myers, Florida, 33916, United States|Florida Cancer Specialists, Gainesville, Florida, 32605, United States|Florida Cancer Specialists, Hudson, Florida, 34667, United States|Florida Cancer Specialists, Largo, Florida, 33770, United States|Florida Cancer Specialists, Naples, Florida, 34102, United States|Florida Cancer Specialists, New Port Richey, Florida, 34655, United States|Florida Cancer Specialists, Orange City, Florida, 32763, United States|Florida Cancer Specialists, Orlando, Florida, 32806, United States|Florida Cancer Specialists, Port Charlotte, Florida, 33980, United States|Florida Cancer Specialists, Saint Petersburg, Florida, 33705, United States|Florida Cancer Specialists, Sarasota, Florida, 34232, United States|Florida Cancer Specialists, Sarasota, Florida, 34236, United States|Florida Cancer Specialists, Spring Hill, Florida, 34608, United States|Florida Cancer Specialists, Tampa, Florida, 33607, United States|Florida Cancer Specialists, Tavares, Florida, 32778, United States|Florida Cancer Specialists, Venice, Florida, 34285, United States|Florida Cancer Specialists, Venice, Florida, 34292, United States|Northwestern Medical Faculty Foundation(NMFF)/ Women's Cancer Center Shared Laboratories, Chicago, Illinois, 60611, United States|Northwestern Medical Faculty Foundation, Chicago, Illinois, 60611, United States|Northwestern Memorial Hospital, Chicago, Illinois, 60611, United States|The University of Chicago Medical Center, Investigational Drug Service Department of Pharmacy, Chicago, Illinois, 60637, United States|The University of Chicago, Chicago, Illinois, 60637, United States|University of Chicago Comprehensive Cancer Center at Silver Cross Hospital, New Lenox, Illinois, 60451, United States|Indiana University Health Hospital, Indianapolis, Indiana, 46202, United States|Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, 46202, United States|Investigational Drug Services, Indianapolis, Indiana, 46202, United States|Sidney and Lois Eskenazi Hospital, Indianapolis, Indiana, 46202, United States|Springmill Medical Clinic, Indianapolis, Indiana, 46290, United States|Oncology Hematology Care, Inc., Crestview Hills, Kentucky, 41017, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|The West Clinic, PC, Corinth, Mississippi, 38834, United States|The West Clinic, PC, Southaven, Mississippi, 38671, United States|Barnes-Jewish Hospital, Saint Louis, Missouri, 63110, United States|Washington University Infusion Center Pharmacy, Saint Louis, Missouri, 63110, United States|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States|Siteman Cancer Center-South County, Saint Louis, Missouri, 63129, United States|Siteman Cancer Center-West County, Saint Louis, Missouri, 63141, United States|Siteman Cancer Center, Saint Peters, Missouri, 63376, United States|Hematology Oncology Associates of Northern NJ, Morristown, New Jersey, 07962, United States|Memorial Sloan Kettering - I Chemotherapy Practice/Investigational Drug Service, New York, New York, 10065, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, United States|Cone Health Cancer Center, Greensboro, North Carolina, 27403, United States|Wesley Long Community Hospital, Greensboro, North Carolina, 27403, United States|Oncology Hematology Care, Inc., Cincinnati, Ohio, 45211, United States|Oncology Hematology Care, Inc., Cincinnati, Ohio, 45219, United States|Oncology Hematology Care, Inc., Cincinnati, Ohio, 45230, United States|Oncology Hematology Care, Inc., Cincinnati, Ohio, 45236, United States|Oncology Hematology Care, Inc., Cincinnati, Ohio, 45242, United States|Oncology Hematology Care, Inc., Fairfield, Ohio, 45014, United States|Greenville Health System, Greenville, South Carolina, 29605, United States|Greenville Health System, Seneca, South Carolina, 29672, United States|Greenville Health System, Spartanburg, South Carolina, 29307, United States|Tennessee Oncology, PLLC, Dickson, Tennessee, 37055, United States|Tennessee Oncology, PLLC, Franklin, Tennessee, 37067, United States|Tennessee Oncology, PLLC, Gallatin, Tennessee, 37066, United States|Tennessee Oncology, PLLC, Hermitage, Tennessee, 37076, United States|Tennessee Oncology, PLLC, Lebanon, Tennessee, 37087, United States|Tennessee Oncology, PLLC, Lebanon, Tennessee, 37090, United States|The West Clinic, PC, Memphis, Tennessee, 38104, United States|The West Clinic, PC, Memphis, Tennessee, 38120, United States|Tennessee Oncology, PLLC, Murfreesboro, Tennessee, 37129, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37203, United States|The Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Vanderbilt Breast Center at One Hundred Oaks, Nashville, Tennessee, 37204, United States|Vanderbilt Health Pharmacy One Hundred Oaks, Nashville, Tennessee, 37204, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37205, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37207, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37211, United States|Henry-Joyce Cancer Clinic, Nashville, Tennessee, 37232, United States|Tennessee Oncology, PLLC, Smyrna, Tennessee, 37167, United States|Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas, 75246, United States|Texas Oncology - Memorial City, Houston, Texas, 77024, United States|Texas Oncology - Longview Cancer Center, Longview, Texas, 75601, United States|Texas Oncology-Tyler, Tyler, Texas, 75702, United States|Virginia Cancer Institute, Mechanicsville, Virginia, 23116-1844, United States|Virginia Cancer Institute, Midlothian, Virginia, 23114, United States|Virginia Oncology Associates, Newport News, Virginia, 23606, United States|Virginia Oncology Associates, Norfolk, Virginia, 23502, United States|Virginia Cancer Institute, Richmond, Virginia, 23230, United States|Virginia Cancer Institute, Richmond, Virginia, 23235-4730, United States|Virginia Oncology Associates, Virginia Beach, Virginia, 23456, United States|UZA, Edegem, Antwerpen, 2650, Belgium|Institut Jules Bordet, Brussels, 1000, Belgium|British Columbia Cancer Agency - Vancouver Centre, Vancouver, British Columbia, V5Z 4E6, Canada|Sunnybrook Research Institute, Toronto, Ontario, M4N 3M5, Canada|McGill University Health Centre-Cedars Cancer Centre, Montreal, Quebec, H4A 3J1, Canada|Department of Radiology, Dooradoyle, Limerick, Ireland|Pharmacy Department, Dublin 4, Ireland|3rd Floor,Oncology Link office, Dublin, 4, Ireland|Department of Radiology, Dublin, 4, Ireland|Institute for Cancer Research, Dublin, 7, Ireland|Mater Private Hospital, Dublin, 7, Ireland|Pharmacy Department, Dublin, 7, Ireland|Radiology Department, Dublin, 7, Ireland|Cancer Clinical Trials Unit, Mid-Western Cancer center, Limerick, Ireland|Pharmacy Department, Limerick, Ireland|Dipartimento di Oncologia Medica, IRCCS Ospedale San Raffaele, Milano, 20132, Italy|Farmacia (magazzino ricevimento merc), IRCCS Ospedale San Raffaele, Milano, 20132, Italy|U.O Farmaceutica, Nuovo Ospedale di Prato Palazzina dei servizi, Prato, 59100, Italy|U.O. Oncologia Medica, Nuovo Ospedale di Prato, Prato, 59100, Italy|Hospital Universitario HM Monteprincipe, Boadilla del Monte, Madrid, 28660, Spain|Grupo Hospitalario Quiron - Hospital Quiron Barcelona, Barcelona, 08023, Spain|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|Hospital Universitario Ramon Y Cajal, Madrid, 28034, Spain|Hospital Universitario 12 Octubre, Madrid, 28041, Spain|Centro Intergral Oncologico Clara Campal, Madrid, 28050, Spain|Hospital de Madrid Norte-Sanchinarro., Madrid, 28050, Spain|Clinical Investigation and Research Unit, Brighton, England, BN2 5BE, United Kingdom|Pharmacy Department, Brighton, England, BN2 5BE, United Kingdom|Radiation Safety Service, Medical Physics Department, Brighton, England, BN2 5BE, United Kingdom|Histopathology Department, Nottingham, England, NG5 1PB, United Kingdom|Nottingham University Hospital, Nottingham, England, NG5 1PB, United Kingdom|Pharmacy Department, Nottingham, England, NG5 1PB, United Kingdom|Radiology Department, Nottingham, England, NG5 1PB, United Kingdom|Radiology Department, Nottingham, England, NG7 2UH, United Kingdom|Royal Cornwall Hospitals NHS trust, Truro, Cornwall, England, TR1 3LJ, United Kingdom|Department of Radiology, Truro, England, TR1 3LJ, United Kingdom|Pharmacy Department, Truro, England, TR1 3LJ, United Kingdom Less << |
NCT02642913 | Hepatocellular Carcinoma | Phase 1 Phase 2 | Recruiting | December 2019 | United States, California ... More >> University of California San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Robin K Kelley, MD 415-353-9888 United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Benjamin Tan, MD 314-747-7222 Principal Investigator: Benjamin Tan, MD United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263-0001 Contact: Iyer Renuka, MD 716-845-2300 Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: James Harding, MD 646-888-4314 Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: James Harding, MD 646-888-4314 Contact: Ghassan Abou-Alfa, MD 646-888-4184 Less << |
NCT01889238 | Advanced, Androgen Receptor Po... More >>sitive Triple Negative Breast Cancer Less << | PHASE2 | COMPLETED | 2024-01-10 | Rocky Mountain Cancer Centers,... More >> Colorado Springs, Colorado, 80907, United States|Rocky Mountain Cancer Centers, Lakewood, Colorado, 80228, United States|Rocky Mountain Cancer Center Sky Ridge, Lone Tree, Colorado, 80124, United States|Rocky Mountain Cancer Centers, Lone Tree, Colorado, 80124, United States|Florida Cancer Specialists, Altamonte Springs, Florida, 32701, United States|Florida Cancer Specialists, Bonita Springs, Florida, 34135, United States|Florida Cancer Specialists, Bradenton, Florida, 34209, United States|Florida Cancer Specialists, Brandon, Florida, 33511, United States|Florida Cancer Specialists, Cape Coral, Florida, 33914, United States|Florida Cancer Specialists, Clearwater, Florida, 33761, United States|Florida Cancer Specialists, Fort Myers, Florida, 33905, United States|Florida Cancer Specialist South Division, Fort Myers, Florida, 33908, United States|Florida Cancer Specialists, Fort Myers, Florida, 33908, United States|Florida Cancer Specialists, Fort Myers, Florida, 33916, United States|Florida Cancer Specialists, Gainesville, Florida, 32605, United States|Florida Cancer Specialists, Hudson, Florida, 34667, United States|Florida Cancer Specialists, Largo, Florida, 33770, United States|Florida Cancer Specialists, Naples, Florida, 34102, United States|Florida Cancer Specialists, New Port Richey, Florida, 34655, United States|Florida Cancer Specialists, Orange City, Florida, 32763, United States|Florida Cancer Specialists, Orlando, Florida, 32806, United States|Florida Cancer Specialists, Port Charlotte, Florida, 33980, United States|Florida Cancer Specialists, Saint Petersburg, Florida, 33705, United States|Florida Cancer Specialists, Sarasota, Florida, 34232, United States|Florida Cancer Specialists, Sarasota, Florida, 34236, United States|Florida Cancer Specialists, Spring Hill, Florida, 34608, United States|Florida Cancer Specialists, Tampa, Florida, 33607, United States|Florida Cancer Specialists, Tavares, Florida, 32778, United States|Florida Cancer Specialists, Venice, Florida, 34285, United States|Florida Cancer Specialists, Venice, Florida, 34292, United States|Northwestern Medical Faculty Foundation(NMFF)/ Women's Cancer Center Shared Laboratories, Chicago, Illinois, 60611, United States|Northwestern Medical Faculty Foundation, Chicago, Illinois, 60611, United States|Northwestern Memorial Hospital, Chicago, Illinois, 60611, United States|The University of Chicago Medical Center, Investigational Drug Service Department of Pharmacy, Chicago, Illinois, 60637, United States|The University of Chicago, Chicago, Illinois, 60637, United States|University of Chicago Comprehensive Cancer Center at Silver Cross Hospital, New Lenox, Illinois, 60451, United States|Indiana University Health Hospital, Indianapolis, Indiana, 46202, United States|Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, 46202, United States|Investigational Drug Services, Indianapolis, Indiana, 46202, United States|Sidney and Lois Eskenazi Hospital, Indianapolis, Indiana, 46202, United States|Springmill Medical Clinic, Indianapolis, Indiana, 46290, United States|Oncology Hematology Care, Inc., Crestview Hills, Kentucky, 41017, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|The West Clinic, PC, Corinth, Mississippi, 38834, United States|The West Clinic, PC, Southaven, Mississippi, 38671, United States|Barnes-Jewish Hospital, Saint Louis, Missouri, 63110, United States|Washington University Infusion Center Pharmacy, Saint Louis, Missouri, 63110, United States|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States|Siteman Cancer Center-South County, Saint Louis, Missouri, 63129, United States|Siteman Cancer Center-West County, Saint Louis, Missouri, 63141, United States|Siteman Cancer Center, Saint Peters, Missouri, 63376, United States|Hematology Oncology Associates of Northern NJ, Morristown, New Jersey, 07962, United States|Memorial Sloan Kettering - I Chemotherapy Practice/Investigational Drug Service, New York, New York, 10065, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, United States|Cone Health Cancer Center, Greensboro, North Carolina, 27403, United States|Wesley Long Community Hospital, Greensboro, North Carolina, 27403, United States|Oncology Hematology Care, Inc., Cincinnati, Ohio, 45211, United States|Oncology Hematology Care, Inc., Cincinnati, Ohio, 45219, United States|Oncology Hematology Care, Inc., Cincinnati, Ohio, 45230, United States|Oncology Hematology Care, Inc., Cincinnati, Ohio, 45236, United States|Oncology Hematology Care, Inc., Cincinnati, Ohio, 45242, United States|Oncology Hematology Care, Inc., Fairfield, Ohio, 45014, United States|Greenville Health System, Greenville, South Carolina, 29605, United States|Greenville Health System, Seneca, South Carolina, 29672, United States|Greenville Health System, Spartanburg, South Carolina, 29307, United States|Tennessee Oncology, PLLC, Dickson, Tennessee, 37055, United States|Tennessee Oncology, PLLC, Franklin, Tennessee, 37067, United States|Tennessee Oncology, PLLC, Gallatin, Tennessee, 37066, United States|Tennessee Oncology, PLLC, Hermitage, Tennessee, 37076, United States|Tennessee Oncology, PLLC, Lebanon, Tennessee, 37087, United States|Tennessee Oncology, PLLC, Lebanon, Tennessee, 37090, United States|The West Clinic, PC, Memphis, Tennessee, 38104, United States|The West Clinic, PC, Memphis, Tennessee, 38120, United States|Tennessee Oncology, PLLC, Murfreesboro, Tennessee, 37129, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37203, United States|The Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Vanderbilt Breast Center at One Hundred Oaks, Nashville, Tennessee, 37204, United States|Vanderbilt Health Pharmacy One Hundred Oaks, Nashville, Tennessee, 37204, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37205, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37207, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37211, United States|Henry-Joyce Cancer Clinic, Nashville, Tennessee, 37232, United States|Tennessee Oncology, PLLC, Smyrna, Tennessee, 37167, United States|Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas, 75246, United States|Texas Oncology - Memorial City, Houston, Texas, 77024, United States|Texas Oncology - Longview Cancer Center, Longview, Texas, 75601, United States|Texas Oncology-Tyler, Tyler, Texas, 75702, United States|Virginia Cancer Institute, Mechanicsville, Virginia, 23116-1844, United States|Virginia Cancer Institute, Midlothian, Virginia, 23114, United States|Virginia Oncology Associates, Newport News, Virginia, 23606, United States|Virginia Oncology Associates, Norfolk, Virginia, 23502, United States|Virginia Cancer Institute, Richmond, Virginia, 23230, United States|Virginia Cancer Institute, Richmond, Virginia, 23235-4730, United States|Virginia Oncology Associates, Virginia Beach, Virginia, 23456, United States|UZA, Edegem, Antwerpen, 2650, Belgium|Institut Jules Bordet, Brussels, 1000, Belgium|British Columbia Cancer Agency - Vancouver Centre, Vancouver, British Columbia, V5Z 4E6, Canada|Sunnybrook Research Institute, Toronto, Ontario, M4N 3M5, Canada|McGill University Health Centre-Cedars Cancer Centre, Montreal, Quebec, H4A 3J1, Canada|Department of Radiology, Dooradoyle, Limerick, Ireland|Pharmacy Department, Dublin 4, Ireland|3rd Floor,Oncology Link office, Dublin, 4, Ireland|Department of Radiology, Dublin, 4, Ireland|Institute for Cancer Research, Dublin, 7, Ireland|Mater Private Hospital, Dublin, 7, Ireland|Pharmacy Department, Dublin, 7, Ireland|Radiology Department, Dublin, 7, Ireland|Cancer Clinical Trials Unit, Mid-Western Cancer center, Limerick, Ireland|Pharmacy Department, Limerick, Ireland|Dipartimento di Oncologia Medica, IRCCS Ospedale San Raffaele, Milano, 20132, Italy|Farmacia (magazzino ricevimento merc), IRCCS Ospedale San Raffaele, Milano, 20132, Italy|U.O Farmaceutica, Nuovo Ospedale di Prato Palazzina dei servizi, Prato, 59100, Italy|U.O. Oncologia Medica, Nuovo Ospedale di Prato, Prato, 59100, Italy|Hospital Universitario HM Monteprincipe, Boadilla del Monte, Madrid, 28660, Spain|Grupo Hospitalario Quiron - Hospital Quiron Barcelona, Barcelona, 08023, Spain|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|Hospital Universitario Ramon Y Cajal, Madrid, 28034, Spain|Hospital Universitario 12 Octubre, Madrid, 28041, Spain|Centro Intergral Oncologico Clara Campal, Madrid, 28050, Spain|Hospital de Madrid Norte-Sanchinarro., Madrid, 28050, Spain|Clinical Investigation and Research Unit, Brighton, England, BN2 5BE, United Kingdom|Pharmacy Department, Brighton, England, BN2 5BE, United Kingdom|Radiation Safety Service, Medical Physics Department, Brighton, England, BN2 5BE, United Kingdom|Histopathology Department, Nottingham, England, NG5 1PB, United Kingdom|Nottingham University Hospital, Nottingham, England, NG5 1PB, United Kingdom|Pharmacy Department, Nottingham, England, NG5 1PB, United Kingdom|Radiology Department, Nottingham, England, NG5 1PB, United Kingdom|Radiology Department, Nottingham, England, NG7 2UH, United Kingdom|Royal Cornwall Hospitals NHS trust, Truro, Cornwall, England, TR1 3LJ, United Kingdom|Department of Radiology, Truro, England, TR1 3LJ, United Kingdom|Pharmacy Department, Truro, England, TR1 3LJ, United Kingdom Less << |
NCT01664923 | Prostate Cancer | Phase 2 | Completed | - | - |
NCT02007512 | Breast Cancer | Phase 2 | Active, not recruiting | March 29, 2019 | - |
NCT01664923 | - | Completed | - | - | |
NCT02294461 | Progressive Metastatic Prostat... More >>e Cancer Less << | Phase 3 | Active, not recruiting | March 2020 | - |
NCT03751436 | Castration Levels of Testoster... More >>one Castration-Resistant Prostate Carcinoma Metastatic Prostate Carcinoma Metastatic Prostate Carcinoma in the Soft Tissue Prostate Carcinoma Metastatic in the Bone PSA Progression Stage IV Prostate Cancer AJCC v8 Stage IVA Prostate Cancer AJCC v8 Stage IVB Prostate Cancer AJCC v8 Less << | Phase 1 Phase 2 | Not yet recruiting | September 2022 | United States, New York ... More >> Roswell Park Cancer Institute Not yet recruiting Buffalo, New York, United States, 14263 Contact: Gurkamal S. Chatta 716-845-3117 Gurkamal.Chatta@roswellpark.org Principal Investigator: Gurkamal S. Chatta Less << |
NCT02064582 | Prostate Cancer | Phase 2 | Active, not recruiting | April 2019 | United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 Less << |
NCT02294461 | - | Active, not recruiting | - | - | |
NCT02955394 | Breast Cancer | Phase 2 | Recruiting | November 2018 | United States, Colorado ... More >> University of Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Tiffany Colvin 720-848-0664 tiffany.colvin@ucdenver.edu Principal Investigator: Anthony D Elias, MD United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Monica Fornier, MD fornierm@mskcc.org Principal Investigator: Monica Fornier, MD United States, Tennessee West Cancer Center Recruiting Germantown, Tennessee, United States, 38138 Contact: Gregory Vidal, MD gvidal@westclinic.com Principal Investigator: Gregory Vidal, MD Less << |
NCT02750358 | Breast Cancer ... More >> Early Stage Triple Negative Breast Cancer Less << | Phase 2 | Active, not recruiting | May 2019 | United States, Connecticut ... More >> Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States, 06102 United States, New Jersey Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States, 07920 Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States, 07748 United States, New York Kings County Hopsital Center Brooklyn, New York, United States, 11203 Coney Island Hospital Brooklyn, New York, United States, 11235 Woodhull Hospital Brooklyn, New York, United States Memorial Sloan Kettering Cancer Center at Commack Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Queens Hospital Center Jamaica, New York, United States, 11432 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 United States, Pennsylvania Lehigh Valley Health Network Allentown, Pennsylvania, United States, 18103 Less << |
NCT01302041 | Prostate Cancer | PHASE2 | COMPLETED | 2017-04-27 | Site BE1003, Brussels, 1090, B... More >>elgium|Site BE1001, Brussels, 1200, Belgium|Site BE1002, Kortrijk, 8500, Belgium|Site BE1005, Leuven, 3000, Belgium|Site CZ3006, Olomouc, 77520, Czechia|Site CZ3002, Praha 6, 16000, Czechia|Site DK4001, Aarhus N, 8200, Denmark|Site DK4004, Copenhagen, DK-2100, Denmark|Site DK4002, Herlev, 2730, Denmark|Site DE5005, Aachen, 51074, Germany|Site DE5007, Bonn, 53111, Germany|Site DE5003, Hannover, 30625, Germany Less << |
NCT01974765 | Advanced Epithelial Ovarian|Re... More >>current Epithelial Ovarian|Fallopian Tube|Primary Peritoneal Carcinoma Less << | PHASE2 | COMPLETED | 2022-02-28 | Memorial Sloan Kettering Cance... More >>r Center at Basking Ridge, Basking Ridge, New Jersey, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, 07748, United States|Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, 11725, United States|Memorial Sloan Kettering Westchester, Harrison, New York, 10604, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Memorial Sloan Kettering Cancer Center at Mercy Medical Center, Rockville Centre, New York, 11570, United States Less << |
NCT02918968 | Prostate Cancer | Phase 4 | Active, not recruiting | March 2020 | Japan ... More >> Site JP00024 Aichi, Japan Site JP00025 Aichi, Japan Site JP00010 Chiba, Japan Site JP00053 Chiba, Japan Site JP00038 Ehime, Japan Site JP00039 Fukuoka, Japan Site JP00040 Fukuoka, Japan Site JP00050 Fukuoka, Japan Site JP00051 Fukuoka, Japan Site JP00005 Gunma, Japan Site JP00043 Gunma, Japan Site JP00045 Gunma, Japan Site JP00035 Hiroshima, Japan Site JP00001 Hokkaido, Japan Site JP00002 Hokkaido, Japan Site JP00048 Hokkaido, Japan Site JP00054 Hokkaido, Japan Site JP00055 Ibaraki, Japan Site JP00019 Kanagawa, Japan Site JP00020 Kanagawa, Japan Site JP00021 Kanagawa, Japan Site JP00044 Kanagawa, Japan Site JP00026 Kyoto, Japan Site JP00006 Nagano, Japan Site JP00008 Nagano, Japan Site JP00041 Nagasaki, Japan Site JP00046 Nara, Japan Site JP00033 Okayama, Japan Site JP00027 Osaka, Japan Site JP00028 Osaka, Japan Site JP00029 Osaka, Japan Site JP00030 Osaka, Japan Site JP00031 Osaka, Japan Site JP00032 Osaka, Japan Site JP00042 Saga, Japan Site JP00009 Saitama, Japan Site JP00022 Shizuoka, Japan Site JP00049 Tochigi, Japan Site JP00037 Tokushima, Japan Site JP00011 Tokyo, Japan Site JP00013 Tokyo, Japan Site JP00014 Tokyo, Japan Site JP00016 Tokyo, Japan Site JP00017 Tokyo, Japan Site JP00018 Tokyo, Japan Site JP00052 Toyama, Japan Site JP00034 Yamaguchi, Japan Less << |
NCT01977651 | Metastatic Castration-resistan... More >>t Prostate Cancer (mCRPC) Less << | PHASE4 | COMPLETED | 2019-01-11 | Site US10005, Anchorage, Alask... More >>a, 99503, United States|Site US10024, Detroit, Michigan, 48202, United States|Site US10026, Bronx, New York, 10461, United States|Site US10001, New York, New York, 10065, United States|Site US10014, New York, New York, 10065, United States|Site US10039, Syracuse, New York, 13210, United States|Site US10016, Durham, North Carolina, 27710, United States|Site US10008, Dallas, Texas, 75231, United States|Site US10025, Seattle, Washington, 98109, United States|Site AR54001, Berazategui, Buenos Aires, B1880BBF, Argentina|Site AR54006, Ciudad Autonoma de BuenosAires, Buenos Aires, C1426ANZ, Argentina|Site AR54002, Buenos Aires, Caba, C1120AAT, Argentina|Site AR54003, Cordoba, 5000, Argentina|Site AR54004, Santa Fe, S3000FFU, Argentina|Site AR54005, Tucuman, 4000, Argentina|Site AU61012, Kogarah, New South Wales, 2217, Australia|Site AU61005, Randwick, New South Wales, 2031, Australia|Site AU61011, Sydney, New South Wales, 2109, Australia|Site AU61001, Tweed Heads, New South Wales, 2485, Australia|Site AU61002, Nambour, Queensland, 4560, Australia|Site AU61007, Adelaide, South Australia, 5042, Australia|Site AU61004, Ballarat, Victoria, 3350, Australia|Site BE32004, Anderlecht, 1070, Belgium|Site BE32001, Kortrijk, 8500, Belgium|Site BE32003, Liege, B-4000, Belgium|Site CA15005, Abbotsford, British Columbia, V2S 3N5, Canada|Site CA15014, Halifax, Nova Scotia, B3H 2Y9, Canada|Site CA15004, Brampton, Ontario, L6T 4S5, Canada|Site CA15010, Scarborough, Ontario, M1S 4V5, Canada|Site CA15001, Quebec City, Quebec, G1R3S1, Canada|Site CL56001, Temuco, IX Region, 4810469, Chile|Site CL56004, Santiago, 8420383, Chile|Site CL56002, Temuco, 4781156, Chile|Site CL56003, Vina del Mar, 2540364, Chile|Site CZ42004, Praha 2, 12000, Czechia|Site CZ42002, Praha 6, 16000, Czechia|Site FI35803, Helsinki, 00290, Finland|Site FI35801, Oulu, 90220, Finland|Site FI35802, Tampere, 33520, Finland|Site FR33002, Lyon Cedex 03, 69437, France|Site FR33004, Rouen Cedex, 76031, France|Site FR33005, Suresnes, 92151, France|Site DE49009, Nürtingen, Baden-Württemberg, 72622, Germany|Site DE49003, Berlin, 12200, Germany|Site DE49001, Munster, 48149, Germany|Site HU36002, Sopron, Gyor-Moson Sopron, 9400, Hungary|Site IL97202, Kfar Saba, HaMerkaz, 44281, Israel|Site IL97201, Be'er Ya'akov, 70300, Israel|Site IL97203, Beer-Sheva, 84101, Israel|Site IL97205, Haifa, 31096, Israel|Site IL97204, Jerusalem, 91120, Israel|Site IL97208, Nahariya, 21000, Israel|Site IL97206, Petah-Tiqva, 49100, Israel|Site IL97207, Ramat Gan, 52621, Israel|Site IT39005, Meldola, Emilia-Romagna, 47014, Italy|Site IT39001, Cremona, Lombardia, 26100, Italy|Site IT39002, Arezzo, 52100, Italy|Site IT39003, Roma, 00144, Italy|Site KR82006, Seongnam-Si, Gyeonggi-do, 013620, Korea, Republic of|Site KR82007, Seoul, 03080, Korea, Republic of|Site KR82003, Seoul, 135-710, Korea, Republic of|Site KR82001, Seoul, 135-720, Korea, Republic of|Site KR82004, Seoul, 137-701, Korea, Republic of|Site NZ64001, Hamilton, 3204, New Zealand|Site SG65002, Singapore, 119228, Singapore|Site ES34007, Hospitalet de Llobregat, Barcelona, 08908, Spain|Site ES34005, Sabadell, Barcelona, 08208, Spain|Site ES34001, Pamplona, Navarra, 31008, Spain|Site ES34003, Barcelona, 08025, Spain|Site ES34004, Barcelona, 08035, Spain|Site ES34006, Madrid, 28050, Spain|Site SE46001, Goteborg, 41345, Sweden|Site SE46002, Orebro, 701 85, Sweden|Site TW88601, Kaohsiung, 81362, Taiwan|Site TW88603, Taipei City, 10048, Taiwan|Site GB44002, Sutton, Surrey, SM2 5PT, United Kingdom Less << |
NCT02203695 | Adenocarcinoma of the Prostate | Phase 2 | Recruiting | August 2025 | United States, District of Col... More >>umbia Sibley Memorial Hospital Recruiting Washington, District of Columbia, United States, 20016 Contact: Ashley Bruns 202-537-4000 abruns3@jhmi.edu United States, Illinois University of Chicago Medical Center Recruiting Chicago, Illinois, United States, 60637 Contact: Fauzia Arif farif@radonc.uchicago.edu United States, Indiana Indiana University Not yet recruiting Lafayette, Indiana, United States, 47904 Contact: Stephanie Middleton 765-838-6871 smiddle3@iuhealth.org United States, Maryland The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21287 Sub-Investigator: Charles Drake, M.D. Sub-Investigator: Hans Hammers, M.D. Sub-Investigator: Emmanuel Antonarakis, M.D. Sub-Investigator: Samuel Denmeade, M.D. Sub-Investigator: Channing Pallar, M.D. Sub-Investigator: Hao Wang, Ph.D. Sub-Investigator: Danny Song, M.D. Sub-Investigator: Mario Eisenberger, M.D. Sub-Investigator: Michael Carducci, M.D. Sub-Investigator: Theodore DeWeese, M.D. Suburban Hospital Recruiting Bethesda, Maryland, United States, 20814 Contact: Barbara Squiller 301-896-2719 bsquill1@jhmi.edu United States, Michigan University of Michigan Health System Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Carolina Fernandez-Castillo cefernan@med.umich.edu Contact: Charles Leister cleister@med.umich.edu Karmanos Cancer Center Recruiting Detroit, Michigan, United States, 48201 Contact: Ted Chaperon chaperon@karmanos.org Principal Investigator: Peter Paximadis Sub-Investigator: Elisabeth Heath United States, Oregon Oregon Health Sciences University Recruiting Portland, Oregon, United States, 97239 Contact: Ryan Stewart stewarry@ohsu.edu Principal Investigator: Arthur Hung United States, Utah University of Utah - Huntsman Cancer Center Not yet recruiting Salt Lake City, Utah, United States, 84112 Less << |
NCT02003924 | Nonmetastatic Castration-Resis... More >>tant Prostate Cancer Prostate Cancer Cancer of the Prostate Less << | Phase 3 | Active, not recruiting | May 31, 2020 | - |
NCT02677896 | Metastatic Hormone Sensitive P... More >>rostate Cancer Less << | Phase 3 | Active, not recruiting | December 2023 | - |
NCT02605863 | Bladder Cancer | PHASE2 | TERMINATED | 2025-02-18 | University of Rochester, Roche... More >>ster, New York, 14642, United States Less << |
NCT02429193 | Castration-resistant Prostate ... More >>Cancer Less << | Phase 2 | Active, not recruiting | June 2018 | Canada, British Columbia ... More >> British Columbia Cancer Agency, Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 Less << |
NCT03700099 | Prostate Cancer ... More >> Castration-resistant Prostate Cancer Less << | Phase 2 | Not yet recruiting | December 2021 | Brazil ... More >> Instituto do Câncer do Estado de São Paulo Not yet recruiting São Paulo, SP, Brazil Contact: Ingrid Barbosa +55 11 3893-3535 ingrid.barbosa@hc.fm.usp.br Principal Investigator: Diogo Assed Bastos, MD Less << |
NCT02605863 | Bladder Cancer | PHASE2 | TERMINATED | 2025-02-18 | University of Rochester, Roche... More >>ster, New York, 14642, United States Less << |
NCT02711956 | Metastatic Castration-Resistan... More >>t Prostate Cancer Less << | Phase 1 Phase 2 | Recruiting | June 2019 | United States, California ... More >> University of California Los Angeles Medical Center Recruiting Los Angeles, California, United States University of California San Francisco Medical Center Recruiting San Francisco, California, United States United States, Michigan Karmanos Cancer Institute Recruiting Detroit, Michigan, United States Karmanos Cancer Institute Recruiting Farmington Hills, Michigan, United States United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States Weill Cornell Medicine - New York Presbyterian Recruiting New York, New York, United States United States, Oregon Oregon Health & Science University Recruiting Portland, Oregon, United States United States, Washington Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States Less << |
NCT03464201 | Ovarian Cancer | Phase 2 | Recruiting | March 2020 | Spain
... More >> Hospital de Mar
Recruiting
Barcelona, Spain
Hospital Reina Sofia
Recruiting
Córdoba, Spain
Hospital Madrid Sanchinarro (CIOCC)
Recruiting
Madrid, Spain
Contact: Garcia-Donas, MD +34 91 756 79 84 jgarciadonas@gmail.com |
NCT02441517 | Metastatic Castration Resistan... More >>t Prostate Cancer Less << | PHASE4 | TERMINATED | 2017-03-15 | Site US10003, Evanston, Illino... More >>is, 60201, United States|Site US10006, Worcester, Massachusetts, 01605, United States|Site US10004, New York, New York, 10029, United States|Site US10001, Charleston, South Carolina, 29425, United States|Site US10002, Myrtle Beach, South Carolina, 29572, United States Less << |
NCT02929576 | Breast Cancer | Phase 3 | Withdrawn(Further understandin... More >>g about the role of androgen signaling in TNBC was required) Less << | - | United States, Kansas ... More >> Topeka, Kansas, United States, 66606 United States, Louisiana Metairie, Louisiana, United States, 70006 United States, New York Bronx, New York, United States, 10469 United States, Texas Houston, Texas, United States, 77030 United States, Washington Tacoma, Washington, United States, 98405 Wenatchee, Washington, United States, 98801 Less << |
NCT02960022 | Prostate Cancer | Phase 2 | Recruiting | July 2021 | - |
NCT02288936 | Hormone-refractory Prostate Ca... More >>ncer Less << | PHASE2 | COMPLETED | 2019-07-22 | Hospital Universitari Germans ... More >>Trias I Pujol de Badalona, Badalona, Barcelona, 08916, Spain|Hospital Universitari Son Espases, Palma de Mallorca, Islas Baleares, 07120, Spain|Hospital Clinic I Provincial de Barcelona, Barcelona, 08036, Spain|Hospital Parc Taulí, Barcelona, Spain|Complejo Hospitalario Regional Reina Sofía, Córdoba, 14004, Spain|Complejo Asistencial Universitario de Leon, León, 24080, Spain|Hospital Universitario Lucus Augusti, Lugo, 27003, Spain|Hospital Ramón Y Cajal, Madrid, 28034, Spain|Hospital Clínico San Carlos, Madrid, 28040, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital General Universitario J.M. Morales Meseguer, Murcia, 30008, Spain|Complejo Hospitalario de Especialidades Virgen de La Victoria, Málaga, 29010, Spain|Complexo Hospitalario Universitario de Ourense, Ourense, 32005, Spain|Complejo Hospitalario Regional Virgen Del Rocio, Sevilla, 41013, Spain|Fundación Instituto Valenciano de Oncologia, Valencia, 46009, Spain|Hospital Universitario Miguel Servet, Zaragoza, 50009, Spain Less << |
NCT03016312 | Prostatic Neoplasms, Castratio... More >>n-Resistant Less << | Phase 3 | Active, not recruiting | July 9, 2022 | - |
NCT03297385 | Prostate Cancer|DNA|Androgen R... More >>eceptor Abnormal Less << | PHASE2 | COMPLETED | 2017-04-01 | - |
NCT03123978 | Metastatic Prostate Carcinoma ... More >> Recurrent Prostate Carcinoma Stage IV Prostate Cancer Less << | Phase 1 | Recruiting | January 2021 | United States, California ... More >> University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Chong-Xian Pan 916-734-3771 cxpan@ucdavis.edu Principal Investigator: Chong-Xian Pan Less << |
NCT01911741 | Healthy Subjects|Castration Re... More >>sistant Prostate Cancer (CRPC)|Relative Bioavailability|MDV3100 Less << | PHASE1 | COMPLETED | 2025-03-13 | Parexel International GmbH, Be... More >>rlin, 14050, Germany Less << |
NCT02441517 | Metastatic Castration Resistan... More >>t Prostate Cancer Less << | PHASE4 | TERMINATED | 2017-03-15 | Site US10003, Evanston, Illino... More >>is, 60201, United States|Site US10006, Worcester, Massachusetts, 01605, United States|Site US10004, New York, New York, 10029, United States|Site US10001, Charleston, South Carolina, 29425, United States|Site US10002, Myrtle Beach, South Carolina, 29572, United States Less << |
NCT02922218 | - | Recruiting | December 2020 | Spain ... More >> Hospital Arquitecto Marcide Recruiting Ferrol, A Coruña, Spain, 15405 Contact: Javier Afonso, MD +34981334000 Franciso.Javier.Afonso.Afonso@sergas.es Hospital Universitario de Santiago Recruiting Santiago de Compostela, A Coruña, Spain, 15706 Contact: Urbano Anido, MD +34981950000 urbanoanido@gmail.com ICO L'Hospitalet Recruiting L'Hospitalet de Llobregat, Barcelona, Spain, 08907 Contact: Josep M. Piulats, MD +34932607780 jmpiulats@iconcologia.net Hospital Althaia Manresa Recruiting Manresa, Barcelona, Spain, 08243 Contact: Montserrat Domenech, MD +34938759300 ext 3309 mdomenech@althaia.cat Hospital de Especialidades de Jerez de la Frontera Recruiting Jerez de la Frontera, Cádiz, Spain, 11407 Contact: Ruth Viciana, MD +34956032075 ruthvician@gmail.com Hospital Costa del Sol Recruiting Marbella, Málaga, Spain, 29603 Contact: Rosa Villatoro, MD +34951976470 villatororoldan@gmail.com Complejo Hospitalario de Navarra Recruiting Pamplona, Navarra, Spain, 31008 Contact: Nuria Lainez, MD +34948255400 ext 5870 nuria.lainez.milagro@cfnavarra.es Hospital Universitario de Canarias Recruiting La Laguna, Tenerife, Spain, 38320 Contact: Rosa Delia Garcia, MD +34922678204 rdgmarrero@gmail.com Fundacion Centro Oncologico de Galicia Recruiting A Coruna, Spain, 15009 Contact: Ana Medina, MD +34981287499 ext 174 ana.medina@cog.es Hospital Universitario Vall D'Hebron Recruiting Barcelona, Spain, 08035 Contact: Rafael Morales, MD +34932746000 ext 4695 rafael.morales.barrera@gmail.com Hospital de Burgos Recruiting Burgos, Spain, 09006 Contact: Guillermo Crespo, MD +34947281978 rescribano@seom.org Contact: Ricardo Sanchez, MD +34947281978 rescribano@seom.org Hospital de Ciudad Real Recruiting Ciudad Real, Spain, 13005 Contact: Jose Carlos Villa, MD +34926278000 ext 77137 jvillaguzman1@yahoo.es Hospital Universitario Reina Sofia Recruiting Cordoba, Spain, 14004 Contact: Maria Jose Mendez, MD +34957011147 mjosemv@yahoo.es Hospital Universitario Virgen de las Nieves Recruiting Granada, Spain, 18014 Contact: Raquel Luque, MD +34958020000 rluquecaro@gmail.com Hospital Universitario de Guadalajara Recruiting Guadalajara, Spain, 19002 Contact: Javier Casinello, MD +34949209200 jacaes@sescam.jccm.es Hospital Universitario Gregorio Maranon Recruiting Madrid, Spain, 28007 Contact: Jose Angel Arranz, MD +34914269070 jarranz@oncomed.gmail.com Coordination PROCURE-Centro Nacional de Investigaciones Oncologicas Recruiting Madrid, Spain, 28029 Contact: Nuria Romero, MD 347328000 ext 2951 nromerol@cnio.es Contact: Berta Nasarre, PhD bnasarre@cnio.es Sub-Investigator: Leticia Rivera, CRA senior Sub-Investigator: Gala Grau, PhD Sub-Investigator: Maria Isabel Pacheco, Technician Sub-Investigator: Teresa Garces, Technician Hospital Universitario Clinico San Carlos Recruiting Madrid, Spain, 28040 Contact: Javier Puente, MD +34913303000 ext 7332 docjavip@yahoo.es Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact: Daniel Castellanos, MD +34913908339 cdanicas@hotmail.com Centro Integral Oncologico Clara Campal Recruiting Madrid, Spain, 28050 Contact: Elena Castro, MD +34917328000 ext 2950 ecastro@hmhospitales.com Hospital Regional Universitario Virgen de la Victoria Recruiting Malaga, Spain, 29010 Contact: Maria Isabel Medina, MD +34951291425 msaez.med@gmail.com Hospital Morales Messeguer Recruiting Murcia, Spain, 30008 Contact: Enrique Gonzalez, MD +34968360900 ext 3807 engonbil@um.es Hospital Virgen de la Victoria Recruiting Málaga, Spain, 29010 Contact: David Olmos, MD 34 91 732 8000 ext 2950 dolmos@cnio.es Contact: Gala Grau, PhD 34697959726 gala.gala.grau.eecc@gmail.com Hospital Son Espases Recruiting Palma de Mallorca, Spain, 07120 Contact: Aranzazu Gonzalez, MD +34871206130 ext 76130 aranzazu.gonzalezdealba@ssib.es Complejo Hospitalario de Pontevedra Recruiting Pontevedra, Spain, 36002 Contact: Cristina Azpitarte, MD +34 986800004 crisazpi@hotmail.com Hospital Universitario La Fe Recruiting Valencia, Spain, 46026 Contact: David Lorente, MD +34961244000 davlorente@hotmail.com Less << | |
NCT03177187 | Metastatic Castration Resistan... More >>t Prostate Cancer Less << | Phase 1 Phase 2 | Not yet recruiting | December 2020 | - |
NCT02384382 | Prostate Carcinoma Metastatic ... More >>to the Bone|Castration Resistant Prostate Cancer Less << | PHASE2 | COMPLETED | 2019-05-03 | Karmanos Cancer Institute, Det... More >>roit, Michigan, 48201, United States|Karmanos Cancer Institute Weisberg Cancer Treatment Center, Farmington Hills, Michigan, 48334, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, 08903, United States|Wimr Pet/Ct, Madison, Wisconsin, 53763, United States|UW Clinical Sciences Center, Madison, Wisconsin, 53792, United States Less << |
NCT02125084 | Prostate Cancer | Phase 1 | Active, not recruiting | January 2019 | United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33916 Florida Cancer Center Saint Petersburg, Florida, United States, 33705 United States, Ohio Oncology Hematology Care Inc. Cincinnati, Ohio, United States, 45242 United States, Tennessee Tennessee Oncology Chattanooga, Tennessee, United States, 37404 Tennessee Oncology PLLC Nashville, Tennessee, United States, 37203 Less << |
NCT02319837 | Hormone Sensitive Prostate Can... More >>cer Prostate Cancer Cancer of the Prostate Less << | Phase 3 | Active, not recruiting | July 31, 2023 | - |
NCT02003924 | - | Active, not recruiting | - | - | |
NCT03336983 | Prostate Cancer ... More >> Bone Metastases Less << | Phase 2 | Recruiting | December 1, 2023 | Italy ... More >> Azienda Ospedaliera Spedali Civili di Brescia Recruiting Brescia, Italy, 25123 Less << |
NCT02495974 | - | Active, not recruiting | March 2019 | - | |
NCT02138799 | Drug-Drug Interaction (DDI) ... More >> Healthy Subjects Pharmacokinetics of Enzalutamide Less << | Phase 1 | Completed | - | Germany ... More >> Parexel International GmbH Berlin, Germany, 14050 Less << |
NCT02116582 | Metastatic Castration-Resistan... More >>t Prostate Cancer Less << | PHASE4 | COMPLETED | 2017-09-29 | Site BE32001, Brussels, Flemis... More >>h Brabant, 1200, Belgium|Site BE32004, Gent, 9000, Belgium|Site BE32007, Hasselt, 3500, Belgium|Site BE32003, Kortrijk, 8500, Belgium|Site BE32002, Liege, 4000, Belgium|Site FR33015, Angers cedex 02, 49055, France|Site FR33009, Caen Cedex 05, 14076, France|Site FR33010, Creteil cedex, 94010, France|Site FR33014, Le Mans, 72015, France|Site FR33013, Lyon Cedex 3, 69003, France|Site FR33003, Marseille CEDEX 9, 13273, France|Site FR33008, Nantes Saint Herblain Cedex, 44805, France|Site FR33002, Nimes, 30029, France|Site FR33001, Paris cedex 15, 75908, France|Site FR33011, Paris, 75005, France|Site FR33007, Rennes, 35042, France|Site FR33005, Suresnes, 92151, France|Site FR33012, Villejiuf, 94805, France|Site DE49005, Nuertingen, Baden-Wuerttemberg, 72622, Germany|Site DE49015, Bergisch Gladbach, Northwest, 51427, Germany|Site DE49017, Duisburg, NRW, 47179, Germany|Site DE49014, Berlin, 10247, Germany|Site DE49003, Berlin, 12200, Germany|Site DE49009, Bonn, 53111, Germany|Site DE49010, Dresden, 01307, Germany|Site DE49016, Duesseldorf, 40225, Germany|Site DE49004, Goettingen, 37075, Germany|Site DE49001, Hamburg, 22081, Germany|Site DE49008, Hamburg, 22399, Germany|Site DE49007, Hannover, 30625, Germany|Site DE49002, Heidelberg, 69120, Germany|Site DE49012, Munster, 48149, Germany|Site DE49006, Tubingen, 72076, Germany|Site ES34004, Santiago de Compostela, A Coruna, 15706, Spain|Site ES34009, Badalona, 8916, Spain|Site ES34011, Barcelona, 08003, Spain|Site ES34006, Barcelona, 08025, Spain|Site ES34008, Barcelona, 08035, Spain|Site ES34001, Madrid, 28007, Spain|Site ES34003, Madrid, 28034, Spain|Site ES34002, Madrid, 28040, Spain|Site ES34010, Madrid, 28044, Spain|Site GB44001, Sutton, Surrey, SM2 5PT, United Kingdom|Site GB44004, Birmingham, B15 2TT, United Kingdom|Site GB44009, Brighton, BN2 5BE, United Kingdom|Site GB44002, Glasgow, G12 0YN, United Kingdom|Site GB44007, London, SE1 9RT, United Kingdom|Site GB44003, Northwood, Middlesex, HA6 2RN, United Kingdom|Site GB44010, Plymouth, PL6 8DH, United Kingdom|Site GB44006, Withington, M204BX, United Kingdom Less << |
NCT02116582 | Metastatic Castration-Resistan... More >>t Prostate Cancer Less << | PHASE4 | COMPLETED | 2017-09-29 | Site BE32001, Brussels, Flemis... More >>h Brabant, 1200, Belgium|Site BE32004, Gent, 9000, Belgium|Site BE32007, Hasselt, 3500, Belgium|Site BE32003, Kortrijk, 8500, Belgium|Site BE32002, Liege, 4000, Belgium|Site FR33015, Angers cedex 02, 49055, France|Site FR33009, Caen Cedex 05, 14076, France|Site FR33010, Creteil cedex, 94010, France|Site FR33014, Le Mans, 72015, France|Site FR33013, Lyon Cedex 3, 69003, France|Site FR33003, Marseille CEDEX 9, 13273, France|Site FR33008, Nantes Saint Herblain Cedex, 44805, France|Site FR33002, Nimes, 30029, France|Site FR33001, Paris cedex 15, 75908, France|Site FR33011, Paris, 75005, France|Site FR33007, Rennes, 35042, France|Site FR33005, Suresnes, 92151, France|Site FR33012, Villejiuf, 94805, France|Site DE49005, Nuertingen, Baden-Wuerttemberg, 72622, Germany|Site DE49015, Bergisch Gladbach, Northwest, 51427, Germany|Site DE49017, Duisburg, NRW, 47179, Germany|Site DE49014, Berlin, 10247, Germany|Site DE49003, Berlin, 12200, Germany|Site DE49009, Bonn, 53111, Germany|Site DE49010, Dresden, 01307, Germany|Site DE49016, Duesseldorf, 40225, Germany|Site DE49004, Goettingen, 37075, Germany|Site DE49001, Hamburg, 22081, Germany|Site DE49008, Hamburg, 22399, Germany|Site DE49007, Hannover, 30625, Germany|Site DE49002, Heidelberg, 69120, Germany|Site DE49012, Munster, 48149, Germany|Site DE49006, Tubingen, 72076, Germany|Site ES34004, Santiago de Compostela, A Coruna, 15706, Spain|Site ES34009, Badalona, 8916, Spain|Site ES34011, Barcelona, 08003, Spain|Site ES34006, Barcelona, 08025, Spain|Site ES34008, Barcelona, 08035, Spain|Site ES34001, Madrid, 28007, Spain|Site ES34003, Madrid, 28034, Spain|Site ES34002, Madrid, 28040, Spain|Site ES34010, Madrid, 28044, Spain|Site GB44001, Sutton, Surrey, SM2 5PT, United Kingdom|Site GB44004, Birmingham, B15 2TT, United Kingdom|Site GB44009, Brighton, BN2 5BE, United Kingdom|Site GB44002, Glasgow, G12 0YN, United Kingdom|Site GB44007, London, SE1 9RT, United Kingdom|Site GB44003, Northwood, Middlesex, HA6 2RN, United Kingdom|Site GB44010, Plymouth, PL6 8DH, United Kingdom|Site GB44006, Withington, M204BX, United Kingdom Less << |
NCT02028988 | Intermediate Risk Prostate Can... More >>cer Less << | Phase 2 | Active, not recruiting | June 2021 | United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less << |
NCT02528643 | - | Active, not recruiting | - | - | |
NCT02528643 | Advanced Hepatocellular Carcin... More >>oma Less << | Phase 2 | Active, not recruiting | May 2019 | - |
NCT02207504 | Castration-resistant Prostate ... More >>Cancer Less << | Phase 1 | Active, not recruiting | December 2018 | United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less << |
NCT02124668 | Castration-Resistant Prostate ... More >>Cancer|Prostate Cancer Less << | PHASE2 | COMPLETED | 2017-05-25 | Site GE99503, Tbilisi, 0144, G... More >>eorgia|Site GE99502, Tbilisi, 0159, Georgia|Site RU70002, Moscow, 115478, Russian Federation|Site RU70003, Moscow, 125284, Russian Federation Less << |
NCT02684227 | Endometrial Cancer | Phase 2 | Recruiting | August 2019 | United States, Texas ... More >> MD Anderson Cancer Center - Memorial City Regional Care Center Recruiting Houston, Texas, United States, 77024 Contact: Appointments 713-358-5300 Principal Investigator: Nicole Fleming, MD University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: MD Anderson Health Information Specialist 877-632-6789 The Woman's Hospital of Houston Recruiting Houston, Texas, United States, 77054 MD Anderson Cancer Center - Katy Regional Care Center Recruiting Houston, Texas, United States, 77094 Contact: Appointments 713-745-9940 Principal Investigator: Nicole Fleming, MD MD Anderson Cancer Center - Bay Area Regional Care Center Recruiting Nassau Bay, Texas, United States, 77058 Contact: Appointments 713-745-9940 Principal Investigator: Nicole Fleming, MD MD Anderson Cancer Center - Sugar Land Regional Care Center Recruiting Sugar Land, Texas, United States, 77478 Contact: Appointments 713-745-9940 Principal Investigator: Nicole Fleming, MD MD Anderson Cancer Center - The Woodlands Recruiting The Woodlands, Texas, United States, 77384 Contact: Appointments 713-745-9940 Principal Investigator: Nicole Fleming, MD Less << |
NCT01942837 | Metastatic Castration-resistan... More >>t Prostate Cancer Less << | PHASE2 | COMPLETED | 2022-09-30 | Brigham and Women's Hospital, ... More >>Boston, Massachusetts, 02115, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|South Shore Hospital, Weymouth, Massachusetts, 02190, United States|University of Washington Medical Center/Seattle Cancer Care Alliance, Seattle, Washington, 98195, United States Less << |
NCT03641560 | Metastatic Castration Resistan... More >>t Prostate Cancer Less << | Phase 4 | Recruiting | May 2020 | India ... More >> Site IN00002 Recruiting Ahmedabad, India Site IN00004 Recruiting Hubli, India Site IN00008 Recruiting Kolkata, India Site IN00003 Recruiting Nashik, India Site IN00007 Recruiting Nashik, India Site IN00001 Recruiting Pune, India Less << |
NCT02138162 | Severe Hepatic Impairment ... More >> Normal Hepatic Function Less << | Phase 1 | Completed | - | Bulgaria ... More >> Comac Medical Ltd. Sofia, Bulgaria, 1612 Less << |
NCT03103724 | Carcinoma Prostate | Phase 2 | Recruiting | March 16, 2019 | Italy ... More >> Elena Verzoni Recruiting Milan, Italy, 20133 Contact: Elena Verzoni, MD +390223904449 Elena.verzoni@istitutotumori.mi.it Contact: Rosanna Montone, Dr.ssa +390223903817 Rosanna.montone@istitutotumori.mi.it Less << |
NCT03196388 | Prostate Carcinoma | PHASE2 | UNKNOWN | 2025-12-18 | Hospital Ramón y Cajal, Madrid... More >>, Spain Less << |
NCT03674814 | Prostate Cancer | Phase 1 | Recruiting | March 10, 2020 | United States, Illinois ... More >> University Of Chicago Medicine Comprehensive Cancer Center Recruiting Chicago, Illinois, United States, 60637 Contact: Julie Gruszczynski 773-834-9961 Jgruszczynski@medicine.bsd.uchicago.edu Principal Investigator: Russell Szmulewitz, MD Less << |
NCT01902251 | Prostate Cancer ... More >> Pharmacokinetics of Enzalutamide Less << | Phase 1 | Completed | - | United States, Colorado ... More >> University of Colorado - Anschutz Medical Campus Denver, Colorado, United States, 80045 United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15232 United States, Texas South Texas Accelerated Research Therapeutics San Antonio, Texas, United States, 78229 Less << |
NCT02500901 | Metastatic Prostate Cancer | Phase 1 | Terminated(Suspended by funder... More >>) Less << | - | United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 Less << |
NCT03207529 | Malignant Neoplasm of Breast | Phase 1 | Not yet recruiting | January 2021 | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations mskaruturi@mdanderson.org Less << |
NCT03328364 | - | Completed | - | Sweden ... More >> Site SE46001 Malmo, Sweden Less << | |
NCT03124615 | Prostate Cancer | PHASE2 | UNKNOWN | 2025-06-21 | Macquarie University, North Ry... More >>de, New South Wales, 2109, Australia Less << |
NCT02953860 | Breast Cancer | Phase 2 | Recruiting | November 2021 | United States, Colorado ... More >> University of Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Tiffany Colvin 303-848-0664 TIFFANY.COLVIN@UCDENVER.EDU Principal Investigator: Anthony D Elias, MD Lone Tree Medical Center Recruiting Lone Tree, Colorado, United States, 80124 Contact: Lisa Lopez lisa.lopez@ucdenver.edu Principal Investigator: Regina Brown, MD United States, Tennessee West Cancer Center Recruiting Germantown, Tennessee, United States, 38138 Contact: Julie Ryder 901-683-0055 jryder@westclinic.com Principal Investigator: Gregory Vidal, MD Less << |
NCT01927627 | Adenocarcinoma of the Prostate | Phase 2 | Active, not recruiting | March 2019 | United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less << |
NCT02911467 | Prostate Cancer | Phase 1 | Recruiting | December 30, 2020 | United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94158 Contact: Rahul Aggarwal, MD 415-353-9278 Rahul.Aggarwal@ucsf.edu Contact: Paula Dutton, BS 415-885-7871 Paula.Dutton@ucsf.edu Less << |
NCT02920229 | 68Ga-PSMA HBED-PET/CT ... More >> Prostate Cancer Less << | Not Applicable | Recruiting | November 2018 | Italy ... More >> Irst Irccs Recruiting Meldola, FC, Italy, 47014 Contact: Federica Matteucci, MD +390543739100 federica.matteucci@irst.emr.it Principal Investigator: Federica Matteucci, MD Sub-Investigator: Ugo De Giorgi, MD Less << |
NCT03170960 | Urothelial Carcinoma ... More >> Renal Cell Carcinoma Non-Small Cell Lung Cancer Castration-resistant Prostate Cancer Triple Negative Breast Cancer Ovarian Cancer Endometrial Cancer Hepatocellular Carcinoma Gastric Cancer Gastroesophageal Junction Adenocarcinoma Colorectal Cancer Head and Neck Cancer Differentiated Thyroid Cancer Less << | Phase 1 Phase 2 | Recruiting | December 2020 | - |
NCT02813226 | Prostate Cancer | Not Applicable | Active, not recruiting | December 2020 | Canada, Ontario ... More >> Juravinski Hospital and Cancer Centre Hamilton, Ontario, Canada London Health Sciences Centre London, Ontario, Canada Sunnybrook-Odette Cancer Centre Toronto, Ontario, Canada Less << |
NCT03075735 | - | Active, not recruiting | December 15, 2018 | - | |
NCT02456571 | - | Recruiting | June 2019 | United States, North Carolina ... More >> Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Monika Anand, PhD 919-681-8838 monika.anand@duke.edu Less << | |
NCT02008058 | - | Active, not recruiting | December 2021 | United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21231 United States, North Carolina Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Washington University of Washington Seattle, Washington, United States, 98109 Less << | |
NCT02398526 | - | Active, not recruiting | September 30, 2023 | Germany ... More >> Multiple Locations, Germany Less << | |
NCT02729103 | - | Completed | - | United States, New Jersey ... More >> Whippany, New Jersey, United States Less << | |
NCT02012920 | Castration-resistant Prostate ... More >>Cancer CRPC Less << | Phase 2 | Active, not recruiting | December 2018 | - |
NCT02202447 | Prostate Cancer | Phase 1 | Active, not recruiting | October 2018 | United States, Arizona ... More >> Scottsdale Healthcare Clinical Trials at the Virginia G. Piper Cancer Center Scottsdale, Arizona, United States, 85258 United States, Connecticut Yale Cancer Center New Haven, Connecticut, United States, 06520 United States, Louisiana Tulane Cancer Center New Orleans, Louisiana, United States, 70112 United States, Nevada Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89169 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10017 United States, Texas South Texas Accelerated Research Therapeutics San Antonio, Texas, United States, 78229 Less << |
NCT02091531 | Metastatic Castration-Resistan... More >>t Prostate Cancer Less << | Phase 2 | Completed | - | United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less << |
NCT00268476 | Prostate Cancer | Phase 2 Phase 3 | Recruiting | September 2024 | - |
NCT03690141 | Castrate-resistant Prostate Ca... More >>ncer (CRPC) Less << | Phase 2 | Recruiting | April 2022 | United States, Connecticut ... More >> Yale Cancer Center Not yet recruiting New Haven, Connecticut, United States, 06510 Principal Investigator: Daniel Petrylak, M.D. United States, Illinois Northwestern University Not yet recruiting Chicago, Illinois, United States, 60611 Contact: Lela Lartey 312-695-1377 emanuela.lartey@northwestern.edu Principal Investigator: Maha Hussain, M.D. United States, Maryland Kimmel Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21205 Contact: Rehab Abdallah 443-253-7021 rabdall1@jhmi.edu Principal Investigator: Michael Carducci, M.D. United States, Michigan Karmanos Cancer Institute Not yet recruiting Detroit, Michigan, United States, 48201 Principal Investigator: Elisabeth Heath, M.D. United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Andrew Atkocius 314-747-1343 a.atkocius@wustl.edu Principal Investigator: Joel Picus, M.D. United States, Nevada Comprehensive Cancer Centers of Nevada Recruiting Las Vegas, Nevada, United States, 89169 Principal Investigator: Nicholas Vogelzang, M.D. United States, Ohio The Urology Group Recruiting Cincinnati, Ohio, United States, 45212 Contact: Bill Corbett 513-841-7555 wcorbett@urologygroup.com Principal Investigator: Marc Pliskin, M.D. United States, Pennsylvania Lancaster Urology Recruiting Lancaster, Pennsylvania, United States, 17604 Contact: Dawn Stern 717-431-2285 Dawns@lancuro.com Principal Investigator: Paul Sieber, M.D. United States, South Carolina Carolina Urologic Research Center Recruiting Myrtle Beach, South Carolina, United States, 29572 Contact: Laura Prince 843-839-1679 lprince@curcmb.com Principal Investigator: Neal Shore, M.D. United States, Washington University of Washington Not yet recruiting Seattle, Washington, United States, 89109 Principal Investigator: Celestia Higano, M.D. Less << |
NCT02494921 | Prostate Cancer | Phase 1 Phase 2 | Recruiting | December 2019 | United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center Active, not recruiting San Francisco, California, United States, 94115 United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Benedito A. Carneiro, MD 312-472-1234 Principal Investigator: Benedito A. Carneiro, MD United States, Michigan University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: David Smith, MD 800-865-1125 Principal Investigator: David Smith, MD Less << |
NCT03763253 | Prostate Cancer ... More >> Metastatic Prostate Cancer Less << | Phase 2 | Not yet recruiting | March 1, 2024 | United Kingdom ... More >> Wirral University Teaching Hospital Not yet recruiting Birkenhead, United Kingdom, CH49 5PE Contact: Manal Kumar, MBBS MS MSh FRCS ED Principal Investigator: Manal Kumar, MBBS MS MSh FRCS ED Broomfield Hospital Not yet recruiting Chelmsford, United Kingdom, CM1 7ET Contact: Casey Rowan, FRCS (Urol) Principal Investigator: Casey Rowan, FRCS (Urol) Ashford and St Peters Not yet recruiting Chertsey, United Kingdom, KT16 0PZ Contact: Nimalan Arumainayagam, FRCS (Urol) Principal Investigator: Nimalan Arumainayagam, FRCS (Urol) Royal Devon and Exeter NHS Trust Not yet recruiting Exeter, United Kingdom, EX2 5DW Contact: John McGrath, BMedSci BMBS FRCS Principal Investigator: John McGrath, BMedSci BMBS FRCS Wycombe General Hospital Not yet recruiting High Wycombe, United Kingdom, HP11 2TT Contact: Neil Haldel, MBBS MB FRCS (Urol) Principal Investigator: Neil Haldel, MBBS MB FRCS (Urol) West Middlesex University Hospital Not yet recruiting Isleworth, United Kingdom, TW7 6AF Contact: Mathias Winkler, MBBS BSc MD FRCS (Urol) Principal Investigator: Mathias Winkler, MBBS BSc MD FRCS (Urol Cambridge Queen Elizabeth hospital, Kings Lynn Not yet recruiting King's Lynn, United Kingdom, PE30 4ET Contact: Gail Horan, MRCPI, FRCR Principal Investigator: Gail Horan, MRCPI, FRCR Guys and St Thomas Hospital Not yet recruiting London, United Kingdom, SE1 7EH Contact: Paul Cathcart, FRCS (Urol) Principal Investigator: Paul Cathcart, FRCS (Urol) St George's Hospital, St. George's University Hospitals NHS Foundation Trust Not yet recruiting London, United Kingdom, SW17 0QT Contact: Hasan Qazi, FRCS (Urol) Principal Investigator: Hasan Qazi, FRCS (Urol) Imperial College Healthcare NHS Trust Not yet recruiting London, United Kingdom, W6 8RF Contact: Hashim U Ahmed, BM, BCh (Oxon), BA, PhD, FRCS Principal Investigator: Hashim U Ahmed, BM, BCh (Oxon), BA, PhD, FRCS Sub-Investigator: Taimur T Shah, MBBS, BSc (Hons), MRCS Sub-Investigator: Martin J Connor, MBBS, BSc (Hons), MSc, MRCS Sub-Investigator: Mathias Winkler, MD, FRCS (Urol) Sub-Investigator: John Staffurth, MD, FRCP, FRCR Sub-Investigator: Alison Falconer, MA, MRCP, FRCR Sub-Investigator: Suraiya Dubash, MBBS, BSc, MRCP, FRCR London North West University Healthcare (Northwick Park) Not yet recruiting London, United Kingdom Contact: Giles Hellawell, MA BM BCH FRCS Principal Investigator: Giles Hellawell, MA BM BCH FRCS Newcastle Hospitals NHS trust (Freeman Hospital) Not yet recruiting Newcastle, United Kingdom, NE7 7DM Contact: Rakesh Heer, PhD FRCS(Urol) Principal Investigator: Rakesh Heer, PhD FRCS(Urol) Glan Clwyd Hospital (Betsi Cadwaladr University Health Board) Not yet recruiting Rhyl, United Kingdom, LL18 5UJ Contact: Kingsley Ekwueme, FRCS (Urol) Principal Investigator: Kingsley Ekwueme, FRCS (Urol) Southampton General Hospital Not yet recruiting Southampton, United Kingdom, SO16 6YD Contact: Tim Dudderidge, FRCS (Urol) Principal Investigator: Tim Dudderidge, FRCS (Urol) Lister Hospital Not yet recruiting Stevenage, United Kingdom, SG1 4AB Contact: Nikhil Vasdev, FRCS (Urol) Principal Investigator: Nikhil Vasdev, FRCS (Urol) Sunderland Royal hospital Not yet recruiting Sunderland, United Kingdom, SR4 7TP Contact: Stuart McCracken, FRCS (Urol) Principal Investigator: Stuart McCraken, FRCS (Urol) Wrexham Maelor Hospital (Betsi Cadwaladr University Health Board) Not yet recruiting Wrexham, United Kingdom, LL13 7TD Contact: Iqbal Shergill, FRCS (Urol) Principal Investigator: Iqbal Shergill, FRCS (Urol) Less << |
NCT02432001 | - | Recruiting | December 2018 | United States, California ... More >> University of California, Davis Recruiting Davis, California, United States, 95616 Contact: Primo Lara, MD University of California, Los Angeles Recruiting Los Angeles, California, United States, 90095 Contact: Matthew Rettig, MD UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94115 Contact: Paula Dutton 415-885-7871 Paula.Dutton@ucsf.edu United States, Oregon Oregon Health & Science University Recruiting Portland, Oregon, United States, 97239 Contact: Tomasz Beer, MD Canada University of British Columbia Recruiting Vancouver, Canada Contact: Kim Chi, MD Less << | |
NCT03551782 | Castration-Resistant Prostatic... More >> Neoplasms Less << | Phase 1 | Recruiting | January 29, 2021 | - |
NCT02606123 | Prostatic Neoplasms ... More >> Genital Neoplasms, Male Genital Diseases, Male Prostatic Diseases Less << | Phase 1 Phase 2 | Terminated(At end of Phase 1 e... More >>xcessive high pill burden (18 capsules/day)) Less << | - | United States, Arizona ... More >> Scottsdale Healthcare Hospitals DBA HonorHealth Scottsdale, Arizona, United States, 85258 United States, Michigan University of Michigan Health System Ann Arbor, Michigan, United States, 48109 Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Canada, British Columbia British Columbia Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 Less << |
NCT03685591 | Hormone Receptor Positive Adva... More >>nced Breast Cancer Metastatic Breast Cancer Human Epidermal Receptor 2 Negative Advanced Breast Cancer Castration Resistant Prostate Cancer Less << | Phase 1 | Recruiting | August 24, 2023 | United States, Texas ... More >> The University of Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030-4009 The University of Texas - MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 NEXT Oncology Recruiting San Antonio, Texas, United States, 78240 Less << |
NCT02826772 | Metastatic Castrate Resistant ... More >>Prostate Cancer (mCRPC) Less << | Phase 1 Phase 2 | Recruiting | December 2018 | United States, Maryland ... More >> Chesapeake Urology Research Associates Recruiting Towson, Maryland, United States, 21204 Contact: Heather Thomas, CCRC 443-471-5742 hthomas@cua.md Contact: Heidi Miller, BScN 514.463.8837 hmiller@accelovance.com Principal Investigator: Richard Levin, MD United States, Nebraska G U Research Network Recruiting Omaha, Nebraska, United States, 68130 Contact: Tony Romero, MS, CCRC 402-697-2229 tromero@gucancer.com Contact: Heidi Miller, BScN 514.463.8837 hmiller@accelovance.com Principal Investigator: Luke T Nordquist, MD United States, Nevada Comprehensive Cancer Centers of Nevada Recruiting Las Vegas, Nevada, United States, 89169 Contact: Khin Win, MBA, MBBS 702-952-3834 khin.win@usoncology.com Contact: Heidi Miller, BScN 514.463.8837 hmiller@accelovance.com Principal Investigator: Nicholas Vogelzang, MD United States, New Jersey Rutgers University Recruiting New Brunswick, New Jersey, United States, 08901 Contact: Tracie Saunders, RN, MS, OCN, CCRC 732-235-8861 tracie.saunders@cinj.rutgers.edu Contact: Heidi Miller, BScN 514.463.8837 hmiller@accelovance.com Principal Investigator: Mark N Stein, MD United States, New York North Shore Hematology Oncology Associates Recruiting East Setauket, New York, United States, 11733 Contact: Don Marx, MBA, MS, RT 631-675-5143 dmarx@nycancer.com Contact: Heidi Miller, BScN 514.463.8837 hmiller@accelovance.com Principal Investigator: Jeffrey L Vacirca, MD, FACP United States, Ohio Gabrail Cancer Center Research Recruiting Canton, Ohio, United States, 44718 Contact: Carrie Smith, RN 484-998-8315 csmith@gabrailcancercenter.com Contact: Heidi Miller, BScN 514.463.8837 hmiller@accelovance.com Principal Investigator: Nashat Gabrail, MD Less << |
NCT03526562 | Prostatic Neoplasms ... More >> Exercise Castration-resistant Prostate Cancer Physical Activity Less << | Not Applicable | Recruiting | October 2018 | Belgium ... More >> University Hospital ghent Recruiting Ghent, Oost-Vlaanderen, Belgium, 9000 Contact: Renée Bultijnck, Msc 932 3320342 renee.bultijnck@ugent.be Contact: Piet Ost, MD, PhD Less << |
NCT02856100 | - | Unknown | December 2018 | United States, Maryland ... More >> Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21287 Contact: Ghedem Solomon, MS 410-614-2789 gsolomo6@jhmi.edu Contact: Akimosa Jeffrey-Kwanisai, MBA 410-502-1040 ajeffre2@jhmi.edu Less << | |
NCT03356912 | Prostate Cancer ... More >> Castration-resistant Prostate Cancer Less << | Phase 2 | Enrolling by invitation | May 4, 2021 | Italy ... More >> University Federico II of Naples Naples, Italy Less << |
NCT03514836 | Castration-resistant Prostate ... More >>Cancer Less << | Phase 1 Phase 2 | Recruiting | April 2021 | Czechia ... More >> Fakultní nemocnice v Motole Recruiting Praha, Czechia, 150 06 Less << |
NCT03050866 | Circulating Tumor Cell ... More >> Metastatic Prostate Cancer Less << | Phase 2 | Recruiting | February 2020 | Netherlands ... More >> Reinier de Graaf Groep Recruiting Delft, Netherlands Contact: A.C.M. Van de Luijtgaarden, MD Principal Investigator: A.C.M. Van de Luijtgaarden, MD Medisch Centrum Haaglanden Recruiting Den Haag, Netherlands Contact: H. Helgason, MD Principal Investigator: H Helgason, MD Groene Hart Ziekenhuis Recruiting Gouda, Netherlands Contact: W. Van der Deure, MD Principal Investigator: W Van der Deure, MD Canisius Wilhelmina Ziekenhuis Recruiting Nijmegen, Netherlands Contact: R. Somford, MD Principal Investigator: R. Somford, MD Erasmus MC Recruiting Rotterdam, Netherlands Contact: Bodine Belderbos caba.v7@erasmusmc.nl Franciscus Gasthuis en Vlietland Recruiting Rotterdam, Netherlands Contact: Paul Hamberg Maasstad Ziekenhuis Recruiting Rotterdam, Netherlands Contact: B. Haberkorn, MD Principal Investigator: B. Haberkorn, MD Tweesteden Ziekenhuid Recruiting Tilburg, Netherlands Contact: A. Coumou, MD Principal Investigator: A Coumou, MD Admiraal de Ruyter Ziekenhuis Recruiting Vlissingen, Netherlands Contact: H.K. Van Halteren, MD Principal Investigator: H.K. Van Halteren, MD Less << |
NCT01695044 | Prostate Cancer | Phase 2 | Completed | - | - |
NCT01695044 | - | Completed | - | - | |
NCT03725761 | Prostate Cancer | Phase 2 | Recruiting | June 1, 2021 | United States, California ... More >> UCSD Moores Cancer Center Not yet recruiting La Jolla, California, United States, 92093 Contact: Candance Winkler 858-822-5398 cmwinkler@ucsd.edu Principal Investigator: Rana McKay, MD United States, Michigan Wayne State University Barbara Ann Karmanos Cancer Institute Not yet recruiting Detroit, Michigan, United States, 48201 Contact: Brenda Dickow 313-576-9372 dickowb@karmanos.org Principal Investigator: Elisabeth Heath, MD United States, Minnesota University of Minnesota Masonic Cancer Center Not yet recruiting Minneapolis, Minnesota, United States, 55455 Contact: Shilpa Gupta 612-625-0571 guptash@umn.edu Principal Investigator: Arpit Rao, MD United States, New York Memorial Sloan-Kettering Cancer Center Not yet recruiting New York, New York, United States, 10065 Contact: Rebecca Green 646-888-1313 borsukr@mskcc.org Principal Investigator: Susan Slovin, MD Weill Cornell Medical College Not yet recruiting New York, New York, United States, 10065 Contact: Jyoti Sreekumar 646-962-9340 jys2004@med.cornell.edu Principal Investigator: Himisha Beltran, MD United States, Wisconsin University of Wisconsin Carbone Cancer Center Recruiting Madison, Wisconsin, United States, 53792 Contact: Mary Jane Staab 608-263-7107 mjs@medicine.wisc.edu Principal Investigator: Christos Kyriakopoulos Less << |
NCT02621190 | Prostatic Neoplasms | Phase 2 | Withdrawn(no approval) | June 2019 | Netherlands ... More >> Erasmus MC Cancer Institute Rotterdam, Netherlands, 3075 EA Less << |
NCT02512185 | - | Recruiting | February 2019 | Canada, Ontario ... More >> Juravinski Cancer Centre Recruiting Hamilton, Ontario, Canada, L8V 5C2 Contact: Sebastien Hotte, MD 905-387- 9711 ext 64605 sebastien.hotte@jcc.hhsc.ca Kingston Health Sciences Centre -KGH Recruiting Kingston, Ontario, Canada, K7L 2V7 Contact: Carrie Lindsay : 613-549-6666 ext 7231 Carrie.Lindsay@kingstonhsc.ca Principal Investigator: Richard Gregg, MD., FRCPC Odette Cancer Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Urban Emmenegger, MD 416-480-4928 urban.emmenegger@sunnybrook.ca Sub-Investigator: Scott Berry, MD Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Henriette Breunis +1-416-946-4501 ext 3926 hbreunis@uhnresearch.ca Principal Investigator: Shabbir Alibhai, MD Sub-Investigator: Anthony Joshua, MD Sub-Investigator: Aaron Hansen, MD Less << | |
NCT02907372 | Metastatic Castration-resistan... More >>t Prostate Cancer (CRPCa) Less << | Not Applicable | Recruiting | November 2020 | France ... More >> CHU Recruiting Amiens, France Contact: Mathieu BOONE, MD Principal Investigator: Mathieu BOONE centre François Baclesse Recruiting Caen, France Contact: Florence JOLY, PhD Principal Investigator: Florence JOLY, PhD Institut régional du Cancer de Montpellier (ICM) Recruiting Montpellier, France Contact: Amélie DARLIX, MD Principal Investigator: Amélie DARLIX, MD Chu Rouen Recruiting Rouen, France Contact: Sophie GOUERANT, MD Principal Investigator: Sophie GOUERANT, MD CHU Not yet recruiting Strasbourg, France Contact: Philippe BARTHELEMY, MD Principal Investigator: Philippe BARTHELEMY, MD IGR Not yet recruiting Villejuif, France Contact: Giulia BACIARELLO, PhD Principal Investigator: Karim FIZAZI, PhD Less << |
NCT02903160 | Prostate Cancer | Phase 2 | Recruiting | October 2019 | United States, New York ... More >> Mount Sinai Beth Israel Recruiting New York, New York, United States, 10011 Contact: Bobby Liaw, MD 212-604-6010 bobby.liaw@mountsinai.org Principal Investigator: Bobby Liaw, MD Mount Sinai West Withdrawn New York, New York, United States, 10019 Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10028 Contact: William Oh, MD 212-659-5549 william.oh@mssm.edu Principal Investigator: William Oh, MD Less << |
NCT03236688 | - | Recruiting | September 2018 | United States, Connecticut ... More >> Yale University School of Medicine Recruiting New Haven, Connecticut, United States, 06520 Contact: Ken F Blount, Ph.D. 203-785-5927 ken.blount@yale.edu Principal Investigator: Daniel Petrylak, MD Less << | |
NCT04142060 | Breast Cancer | PHASE2 | TERMINATED | 2022-10-10 | ICO Badalona, Badalona, Barcel... More >>ona, Spain|Institut Català d'Oncologia Hospitalet, Hospitalet de Llobregat, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitari Vall d' Hebrón, Barcelona, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Universitario Fundación de Alcorcón, Madrid, Spain|Hospital Universitario Virgen del Rocio, Sevilla, Spain|Fundación Instituto Valenciano de Oncología, Valencia, 46009, Spain Less << |
NCT03927391 | Prostatic Neoplasms, Castratio... More >>n-Resistant Less << | PHASE4 | COMPLETED | 2024-01-08 | CWZ, Nijmegen, Netherlands|Rad... More >>boudumc, Nijmegen, Netherlands|Franciscus Gasthuis en Vlietland hospital, Rotterdam, Netherlands Less << |
NCT00510718 | Prostate Cancer|Hormone Refrac... More >>tory Prostate Cancer Less << | PHASE1 | COMPLETED | 2018-04-02 | Dana-Farber Cancer Institute (... More >>DFCI), Boston, Massachusetts, 02115, United States|Beth Israel Deaconess Medical Center (BIDMC), Boston, Massachusetts, 02215, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, United States|MSKCC- Sidney Kimmel Center, New York, New York, 10065, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|Investigational Pharmacy Services, Houston, Texas, 77030-4009, United States|The University of Texas M.D. Anderson Cancer Center, Houston, Texas, 77030-4009, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|University of Washington Medical Center, Seattle, Washington, 98195, United States Less << |
NCT06015321 | Prostatic Adenocarcinoma | PHASE2 | NOT_YET_RECRUITING | 2026-04-30 | Samsung Medical Center, Seoul,... More >> Korea, 06531, Korea, Republic of Less << |
NCT01284920 | Prostate Cancer|Prostate Neopl... More >>asms|Castration Resistant Prostate Cancer (CRPC) Less << | PHASE1|PHASE2 | COMPLETED | 2014-07-02 | Chubu, Japan|Chugoku, Japan|Ho... More >>kkaido, Japan|Kansai, Japan|Kanto, Japan|Kyusyu, Japan|Shikoku, Japan Less << |
NCT01606982 | Metastatic Castration-Resistan... More >>t Prostate Cancer Less << | APPROVED_FOR_MARKETING | - | - | |
NCT01534052 | Castration-Resistant Prostate ... More >>Cancer (CRPC) Less << | PHASE2 | COMPLETED | 2017-04-18 | Site US107, Aurora, Colorado, ... More >>80045, United States|Site US104, Chicago, Illinois, 60637, United States|Site US105, Pittsburgh, Pennsylvania, 15215, United States|Site US106, San Antonio, Texas, 78253, United States|Site MD37301, Chisinau, Moldova, Republic of|Site ZA2701, George, 6529, South Africa|Site ZA2702, Port Elizabeth, 6001, South Africa Less << |
NCT04290611 | Prostate Cancer|Neuropathy|Epi... More >>lepsy|Encephalopathy Less << | COMPLETED | 2023-04-08 | Centre d'Investigation Cliniqu... More >>e H?pital Pitié-Salpêtrière, Paris, 75013, France Less << | |
NCT04456049 | COVID-19 Infection | PHASE2 | TERMINATED | 2021-06-09 | Oncology Institute of Southern... More >> Switzerland (IOSI), Bellinzona, 6500, Switzerland Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.15mL 0.43mL 0.22mL |
10.77mL 2.15mL 1.08mL |
21.53mL 4.31mL 2.15mL |